- Ziektegerelateerd > Pijn bij Patiënten met Kanker
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline

Laatst gewijzigd: 2019-12-06, Versie: 3.0, Verantwoording: Nederlandse Vereniging voor Anesthesiologie, Type: Landelijke richtlijn


1 - Abdalla EK (1999)
Abdalla EK, Schell SR. Paraplegia following intraoperative celiac plexus injection. J Gastrointest Surg 1999;3:668- 71. [link]
2 - Abratt RP (2004)
Abratt RP, Brune D, Dimopoulos MA, et al. Randomised phase III study of intravenous vinorelbine plus hormone therapy versus hormone therapy alone in hormone-refractory prostate cancer. Ann Oncol 2004;15:1613- 21. [link]
3 - Abs R (2000)
Abs R, Verhelst J, Maeyaert J, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22. [link]
4 - Acalovschi I (1994)
Acalovschi I, Bodolea C, Slabu. Therapeutic effect of ondansetron and propofol on neuroaxial opioid-induced pruritus. Anesthesiology 1994;81:591-601.
5 - AGS Panel (2002)
AGS Panel on Persistent Pain in Older Patients. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50:S205-24.
6 - Ahles TA (1999)
Ahles TA, Tope DM, Pinkson B, et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage 1999; 18(3): 157–63. [link]
7 - Ahmedzai S (1997)
Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, ef?cacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. Journal of Pain and Symptom Management 1997;13(5):254–61. [link]
8 - Ahmedzai SH (2010)
Ahmedzai SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid. 2010; 2010. pii: 2407. [link]
9 - Ahonen A (1994)
Ahonen A, Joensuu H. Samarium-153-EDTMP in bone metastases. J Nucl Biol Med 1994;38(4 Suppl 1):123-7 [link]
10 - Algan S (1996)
Algan S, Horowitz S. Surgical treatment of pathological hip lesion in patients with metastatic disease. Clin Orthop Relat Res 1996;332:223-31. [link]
11 - Ali FF (1990)
Ali FF. The effect of individual hypnosis on stress, anxiety, and intractable pain experienced by Lebanese cancer patients. [Unpublished doctoral dissertation.] San Diego, CA: United States International University, 1990.
12 - Allal A (2003)
Allal A, Nicoucar K, Mach N. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy. Head Neck 2003;25:833-9. [link]
13 - Amano K (1991)
Amano K, Kawamura H, Tanikawa T, et al. Bilateral versus unilateral percutaneous high cervical cordotomy as a surgical method of pain relief. Acta Neurochir Suppl (Wien) 1991; 52: 143-5 [link]
14 - Ampil F (2001)
Ampil F, Sadasivan K. Prophylactic and therapeutic fixation of weight-bearing long bones with metastatic cancer. South Med J 2001;94:394-6. [link]
15 - Amr YM (2010)
Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain 2010;26(5):381-5. [link]
16 - Anderson KO (2004)
Anderson KO, Mendoza TR, Payne R, et al. Pain education for underserved minority cancer patients: a randomized controlled trial. Journal of Clinical Oncology 2004;22(24):4918-25. [link]
17 - Anderson H (2000)
Anderson H, Hopwood P, Stephens RJ, et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperablenon-small cell lung cancer – a randomized trial with quality of life as the primary outcome. Br J Cancer 2000;83:447-53. [link]
18 - Anderson KO (2006)
Anderson KO, Cohen MZ, Mendoza TR, et al. Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer 2006; 107: 207. [link]
19 - Anderson KO (2004)
Anderson KO, Mendoza TR, Payne R, et al. Pain education for underserved minority cancer patients: a randomized controlled trial. Journal of Clinical Oncology 2004;22(24):4918-25. [link]
20 - Arai YC (2010)
Arai YC, Matsubara T, et al. Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine. Journal of Anesthesia 2010;24(3):407-410. [link]
21 - Arbaiza D (2007)
Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Invest 2007;27:75-83. [link]
22 - Arbit E (1989)
Arbit E, Galicich JH, Burt M, et al. Modified open thoracic rhizotomy for treatment of intractable chest wall pain of malignant etiology. Ann Thorac Surg 1989;48:820-3. [link]
23 - Arcidiacono Paolo G (2011)
Arcidiacono Paolo G, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007519. doi: 10.1002/14651858.CD007519.pub2. [link]
24 - Aronoff GM (2000)
Aronoff GM. Opioids in chronic pain management: is there a significant risk of addiction? Curr Rev Pain 2000; 6: 305-314. [link]
25 - Ashamalla H (2003)
Ashamalla H, Zaki B, Mokthar B. Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectabel pancreatic cancer. Int J Rad Onc Biol Phys 2003;55:679-87. [link]
26 - Assal M (2000)
Assal M, Zanone X. Osteosynthesis of metastatic lesions of the proximal femur with a solid femoral nail and interlocking spiral blade inserted without reaming. J Orthop Trauma 2000;14:394-7. [link]
27 - Assersohn L (2004)
Assersohn L, Brown G, Cunningham D, et al. Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 2004;15:64-9. [link]
28 - Atanasiu J (1993)
Atanasiu J, Badatcheff F. Metastatic lesions of the cervical spine. A retrospective analysis of 20 cases. Spine 1993;18:1279-84. [link]
29 - Athwal G (2005)
Athwal G, Chin P. Coonrad-Morrey total elbow arthorplasty for tumours of the distal humerus and elbow. J Bone Joint Surg Br 2005;87:1369-74. [link]
30 - Axelsson B (2003)
Axelsson B, Christensen SB. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomised controlled study. Palliat Med 2003; 17: 724-725. [link]
31 - Axelsson B (2008)
Axelsson B, Stellborn P, Ström g. Analgesic effect of paracetamol on cancer related pain in concurrent strong opioid therapy. A prospective clinical study. Acta Oncolog 2008; 47: 891-895 [link]
32 - Azevedo São Leão Ferreira K (2006)
Azevedo São Leão Ferreira K, Kimura M, Jacobsen Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer 2006; 14(11):1086-93. [link]
33 - Babul N (1998)
Babul N, Provencher L, Laberge F, Harsanyi Z, Moulin D. Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain. J Clin Pharmacol 1998; 38: 74-81. [link]
34 - Balducci L (2000)
Balducci L, Berghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000;35:147-54. [link]
35 - Balducci L (2003)
Balducci L. Management of cancer pain in geriatric patients. J Supp Oncology 2003;1:175-91. [link]
36 - Ballantyne JC (2005)
Ballantyne JC, Carwood CM. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database Syst Rev 2005; (1): CD005178. [link]
37 - Bandieri E (2016)
Bandieri E, Romero M, Ripamonti C, et al. Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol 2016; 34: 436-442. [link]
38 - Banerjee M (2013)
Banerjee M, Pal S, Bhattacharya B, et al. A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy. Indian J Pharmacol 2013;45(4):334-8. [link]
39 - Barr J (2000)
Barr J, Barr M. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine 2000;25:923-8. [link]
40 - Bastami S (2012)
Bastami S, Frödin T, Ahlner J, Uppugunduri S. Topical morphine gel in the treatment of painful leg ulcers, a double-blind, placebo-controlled clinical trial: a pilot study. Int Wound J 2012; 9(4): 419-27. [link]
41 - Bauman G (2005)
Bauman G, Charette M. Radiopharmaceuticals for the palliation of painful bone metastases-a systematic review.Radiother Oncol 2005;Jun;75(3):258-70. [link]
42 - Beaver WT (1978)
Beaver WT, Wallenstein SL, Rogers A, et al. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intra- muscular morphine and codeine. J Pharmacol Exp Therapeut 1978;207:101–108. [link]
43 - Bedard G (2013)
Bedard G, Hawley P, Zhang L, et al. Perspectives on the characteristics and treatment of breakthrough pain. Supportive Care Cancer 2013;21(9):2557-63. [link]
44 - Beernaert K (2013)
Beernaert K, Cohen J, Deliens L, et al. Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir Med 2013;107(11):1731-9. [link]
45 - Bell RF (2003)
Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2003;(1):CD003351. [link]
46 - Bennett MI (2011)
Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. [Review]. Palliative Med 2011;25(5):553-9. [link]
47 - Bennett M (2001)
Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92(1- 2):147-57. [link]
48 - Bennett MI (2010)
Bennett MI, Johnson MI, Brown SR, et al. Feasibility study of transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. J Pain 2010; 11: 351-359. [link]
49 - Bennett MI (2013)
Bennett MI, Laird B, van LC, et al. Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med (USA) 2013;14(11):1681-8. [link]
50 - Benzon HT (2006)
Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM, eds. Essentials in Regional Anesthesia: Churchill Livingstone; 2006.
51 - Berenson JR (2002)
Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, et al. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719-3736. [link]
52 - Bergmann JF (1994)
Bergmann JF, Chassany O, Gandiol J, et al. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal 1994; 29: 41-7. . [link]
53 - Bernabei R (1998)
Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA 1998;279:1877-82. [link]
54 - Bernard SA (2000)
Bernard SA, Bruera E. Drug interactions in palliative care. J Clin Oncol 2000;18:1780-99. [link]
55 - Bernard SA (2002)
Bernard SA. The interaction of medications used in palliative care. Hematol Oncol Clin North Am 2002;16:641– 655. [link]
56 - Besse TC (2014)
Besse TC, Vissers KCP. Opioïdgeïnduceerde hyperalgesie in de palliatieve zorg. Bijblijven 2014; 30: 25-31.
57 - Bezjak A (2002)
Bezjak A, Adam J. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002;38:487-96. [link]
58 - Bickels J (2005)
Bickels J, Kollender Y. Function after resection of humeral metastases:analysis of 59 consecutive patients. Clin Orthop Relat Res 2005;437:201-8. [link]
59 - Bilsky M (2000)
Bilsky M, Boland P. Single-stage posterolateral transpedicle approach for spondylectomy, epidural decompression, and circumferential fusion of spinal metastases. Spine 2000;25:2240-9. [link]
60 - Bjorkman R (1993)
Bjorkman R, Ullman A, Hedner J. Morphine-sparing effect of diclofenac in cancer pain. Eur J Clin Pharmacol 1993; 44: 1-5. [link]
61 - Bleehen NM (1993)
Bleehen NM, Girling DJ, Machin D, Stephens RJ. A randomized trial of three versus six courses of etoposide, cyclophosphamide, methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer II: quality of life. Medical Research Council Lung Cancer Working Party. Br J Cancer 1993;68:1157-66. [link]
62 - Boccardo F (1990)
Boccardo F, Decensi A, Guarneri D, et al. Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Eur Urol 1990;18(Suppl 3):48-53. [link]
63 - Boersma FP (1996)
Boersma FP, Kleef M van, Rohof OJJM, et al. Richtlijnen Anesthesiologische Pijnbestrijding: Sectie Pijnbestrijding N.V.A., 1996.
64 - Bordeleau L (2003)
Bordeleau L, Szalai JP, Ennis M, et al. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data. J Clin Oncol 2003; 21: 1944-51. [link]
65 - Borgeat A (1999)
Borgeat A, Stirnemann HR. Ondansetron is effective to treat spinal or epidural morphine-induced pruritus. Anesthesiology 1999;90:432-6. [link]
66 - Bosek V (1994)
Bosek V, Miguel R. Comparison of morphine and ketorolac for intravenous patient-controlled analgesia in postoperative cancer patients. Clin J Pain 1994;10:314-8. [link]
67 - Bosek V (1996)
Bosek V, Cox CE. Comparison of analgesic effect of locally and systemically administered ketorolac in mastectomy patients. Ann Surg Oncol 1996;3: 62-6. [link]
68 - Bosilkovska M (2012)
Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules. Analgesics in patients with hepatic impairment. Drugs 2012; 72: 1645-1669. [link]
69 - Boyd C (2016)
Boyd C, Crawford C, Paat CF, et al. The Impact of Massage Therapy on Function in Pain Populations-A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations. Pain Med 2016; 17: 1553-1568. [link]
70 - Bredlau AL (2013)
Bredlau AL, Thakur R, Korones DN, et al. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature. Pain Med (USA) 2013;14(10):1505-17. [link]
71 - Breul J (1997)
Breul J, Jakse G, Forster G, et al. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resis- tant prostate cancer: a prospective randomized pilot trial. Eur Urol 1997;32:280-3. [link]
72 - Brink-Muinen A den (2004)
Brink-Muinen A den. Oog voor communicatie huisarts-patiënt: communicatie in Nederland. Utrecht: Nivel, 2004.
73 - Bruera E (1998)
Bruera E, Belzile M, Pituskin E, et al. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. Journal of Clinical Oncology 1998;16(10): 3222–9. [link]
74 - Bruera E (1992)
Bruera E, Fainsinger R, MacEachern, et al. The use of methylphenidate in patients with incident cancer pain receiving regular opiates: A preliminary report. Pain 1992;50:75-7. [link]
75 - Bruera E (2004)
Bruera E, Palmer JL, Bosnjak S, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. Journal of Clinical Oncology 2004;22(1):185–92. [link]
76 - Bruera E (1992)
Bruera E, Ripamonti C, Brenneis C, et al. A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain. Journal of pain and symptom management 1992;7(3):138-40. [link]
77 - Bruera E (1985)
Bruera E, Roca E, Cedaro L, et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomised double-blind study. Cancer Treatm Rep 1985;69:751-4. [link]
78 - Brunelli C (2010)
Brunelli C, Zecca E, Martini C, et al. Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 2010;8:42. [link]
79 - Burris HA (1997)
Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13. [link]
80 - Bydder S (2003)
Bydder S, Spry N, Christie D. A prospective trial of short-fractionation radiotherapy for the palliation of liver metastases. Australas Radiol 2003;47:284-8. [link]
81 - Callstrom MR (2006)
Callstrom MR, Charboneau JW, Goetz MP. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 2006;35:1-15. [link]
82 - Campbell FA (2001)
Campbell FA, Tramèr MR, Carroll D, et al. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001;323(7303):13-6. [link]
83 - Candido K (2003)
Candido K, Stevens RA. Intrathecal neurolytic blocks for the relief of cancer pain. Best Pract Res Clin Anaesthesiol 2003; 17: 407-28. [link]
84 - Caraceni A (2013)
Caraceni A, Davies A, Poulain P, et al. Guidelines for the management of breakthrough pain in patients with cancer. JNCCN J Nat Compr Cancer Netw 2013;11(SUPPL.1):S29-S36. [link]
85 - Caraceni A (2012)
Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012; 13: e58-68. doi: 10.1016/S1470-2045(12)70040-2. [link]
86 - Caraceni A (1999)
Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. Pain1999; 82: 263-274. [link]
87 - Cariati M (2002)
Cariati M, Martini G de, Pretolesi F, et al. CT-guided superior hypogastric plexus block. J Comput Assist Tomogr 2002;26:428-31. [link]
88 - Carlson CL (2016)
Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. J Pain Res 2016; 22;9: 515-34. [link]
89 - Carlson RW (1990)
Carlson RW, Borrison RA, Sher HB, et al. A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine and placebo in cancer pain. Pharmacotherapy 1990; 10: 211-6. [link]
90 - CBO (2005)
CBO Richtlijn Delirium 2005.
91 - CBO (2014)
CBO, Zorgmodule Zelfmanagement 1.0. 2014.
92 - Centeno C (2004)
Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliative Medicine 2004;18:184-94. [link]
93 - Chang VT (2006)
Chang VT, Janjan N, Jain S, et al. Update in cancer pain syndromes. J Palliat Med 2006; 9: 1414-1434. [link]
94 - Charuluxananan S (2000)
Charuluxananan S, Somboonviboon W, Kyokong O, et al. Ondansetron for treatment of intrathecal morphine- induced pruritus after cesarean delivery. Regional Anesthesia and Pain Medicine 2000;25:535-9. [link]
95 - Chary S (1994)
Chary S, Goughnour BR, Moulin DE, et al. The dose-response relationship of controlled release codeine (Codeine Contin) in chronic cancer pain. J Pain Symptom Manage 1994; 9: 363-71. [link]
96 - Chen ML (2004)
Chen ML, Chang HK. Physical symptom profiles of depressed and nondepressed patients with cancer. Palliative Medicine 2004;18:712-718. [link]
97 - Chen TH (2016)
Chen TH, Tung TH, Chen PS, et al. The Clinical Effects of Aromatherapy Massage on Reducing Pain for the Cancer Patients: Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2016; 2016:9147974. 10,1155/2016/9147974. [link]
98 - Cherny N (2001)
Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542-54. [link]
99 - Cheung G (2006)
Cheung G, Chow E. Percutaneous vertebroplasty in patients with intractable pain from osteoporotic or metastatic fractures: A prospective study using quality-of-life assessment. Can Assoc Radiol J 2006;57:13-21. [link]
100 - Cheville AL (2013)
Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patiënts with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013; 45: 811-21. [link]
101 - Chey WD (2014)
Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014; 370: 2387-2396. [link]
102 - Chow E (2007)
Chow E, Loblaw A, Harris K, et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a pilot study. Supportive Care Cancer 2007;15(6):643-7. [link]
103 - Clark AJ (2004)
Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fentanyl and sustained-release oralmorphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 2004;20:1419-28. [link]
104 - Cleary JF (1997)
Cleary JF, Carbone PP. Palliative medicine in the elderly. Cancer 1997;80:1335-47. [link]
105 - Cleeland CS (2013)
Cleeland CS, Body JJ, Stopeck A, et al. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer 2013;119(4):832-8. [link]
106 - Cleeland CS (1994)
Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. New Engl J Med1994;330:592-6. [link]
107 - Clemens KE (2012)
Clemens KE, Faust M. Drug interactions in palliative care patients with intractable cancer pain and polypharmacy: Focus on hydromorphone. Palliative Med 2012;26(4):564-5.
108 - Coates A (1987)
Coates A, Gebski V, Stat M, et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. New Engl J Med 1987;317:1490-5. [link]
109 - Colak A (2004)
Colak A, Kutlay M. Two-staged operation on C2 neoplastic lesions: anterior excision and posterior stabilisation. Neurosurg Rev 2004;27:189-93. [link]
110 - Coleman RE (2004)
Coleman RE. Bisphosphonates: clinical experience. The Oncologist 2004;9(suppl 4):14-27. [link]
111 - College ter Beoordeling van Geneesmiddelen (2006)
College ter Beoordeling van Geneesmiddelen CBG,1-B teksten 2006. [link]
112 - Collinge W (2013)
Collinge W, Kahn J, Walton T, et al. Touch, caring, and cancer: Randomized controlled trial of a multimedia caregiver education program. Support Care Cancer 2013; 21(5): 1405–14. [link]
113 - Coluzzi PH (2001)
Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001;91(1- 2):123-30. [link]
114 - Cooper JS (1999)
Cooper JS, Guo MD, Herskovic A. hemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-7. [link]
115 - Cooper MG (1994)
Cooper MG, Keneally JP, Kinchington D. Continuous brachial plexus neural blockade in a child with intractable cancer pain. J Pain Symptom Manage 1994;9:277-81. [link]
116 - Corli O (1993)
Corli O, Cozzolino A, Scaricabarozzi I. Nimesulide and diclofenac in the control of cancer-related pain. Comparison between oral and rectal administration. Drugs 1993; 46(Suppl 1): 152-5. [link]
117 - Cormie P (2013)
Cormie P, Newton RU, Spry N, et al. Safety and efficacy of resistance exercise in prostate cancer patiënts with bone metastases. Prostate Cancer Prostatic Dis 2013; 16: 328-35. [link]
118 - Corry J (2005)
Corry J, Peters LJ, Costa ID. The QUAD SHOT-a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005;77:137-42. [link]
119 - Cousins MJ (2008)
Cousins MJ, Bridenbaugh P, Carr D, et al. Neural Blockade in Clinical Anesthesia and Pain Medicine 4th ed: Lippencott-Raven; 2008.
120 - Crane C (2001)
Crane C, Janjan N, Abbruzzese J. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Rad Onc Biol Phys 2001;49:107-16. [link]
121 - Crul BJP (2005)
Crul BJP, Blok LM, Egmond J van, et al. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain 2005; 6: 24-9. [link]
122 - Cubero DI (2010)
Cubero DI, del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer 2010; 18: 235-42. [link]
123 - Da Silva FC (1993)
Da Silva FC. Quality of life in prostatic carcinoma. Eur Urol 1993;24(Suppl 2):113-7. [link]
124 - Daeninck PJ (1999)
Daeninck PJ, Bruera. Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases. J Pain Symptom Manage 1999;18:303-9. [link]
125 - Dale O (2011)
Dale O, Moksnes K, Kaasa S, et al. European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 2011;25(5):494- 503. . [link]
126 - Dancey J (2004)
Dancey J, Shepherd FA, Gralla R, et al. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 2004;43:183-94.
127 - Davies A (2011)
Davies A, Zeppetella G, Andersen S, et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011;13:756-763. [link]
128 - Davies AN (2005)
Davies AN, Vriens J. Oral transmucosal fentanyl citrate and xerostomia. J Pain Symptom Manage 2005;30:496-7. [link]
129 - Davies A (2012)
Davies A, Zeppetella G, Rios C, et al. The efficacy of opioids for the treatment of breakthrough cancer pain: A network meta-analysis. Palliative Med 2012;26(4):428.
130 - Davies AN (2009)
Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009; 13(4): 331-8. [link]
131 - Davis MP (2005)
Davis MP, Walsh D, Lagman R, et al. Controverses in pharmacotherapy of pain management. Lancet Oncol 2005; 6: 696-704. [link]
132 - Davis MP (2004)
Davis MP, Weissman DE, Arnold RM. Opioid dose titration for severe cancer pain: a systematic evidence-based review. J Palliat Med 2004;7:462-468. [link]
133 - De Graeff A (2006)
De Graeff A, Verhagen EH, Besse TC, Crul BJP, Krol RJA. Richtlijn pijn. In: De Graeff A, Hesselmann GM, Krol RJA, Kuyper MB, Verhagen EH, Vollaard EJ. Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging van Integrale Kankercentra, 2006, pp 565-621).
134 - De Wit (1997)
De Wit, van DF, Zandbelt L, et al. A pain education program for chronic cancer pain patients: follow-up results from a randomized controlled trial. Pain (03043959) 1997;73(1):55-69. [link]
135 - Dean M (2004)
Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 2004;28:497-504. [link]
136 - Deandrea S (2014)
Deandrea S, Corli O, Consonni D, et al. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76. [link]
137 - Deandrea S (2009)
Deandrea S, Corli O, Moschetti I, et al. Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review. Therapeutics & Clinical Risk Management 2009;5(5):707-18. [link]
138 - Dearnaly DP (2003)
Dearnaly DP, Sydes MR, Mason MD, Stott M, Powell CS, Robinson AC, et al. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J Natl Cancer Inst 2003;95:1300-1311. [link]
139 - Deer TR (2002)
Deer TR, Caraway DL, Kim CK, et al. Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. Spine J 2002; 2: 274-8. [link]
140 - Deer TR (2017)
Deer TR, Pope JE, HayekSM et al: The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines. Neuromodulation 2017; 20: 96–132. [link]
141 - Delgado-Guay MO (2008)
Delgado-Guay MO. Management of pain in the older person with cancer. Part 2: Treatment options. Oncology (Williston Park) 2008; 22: 148–152. [link]
142 - Della Cuna GR (1989)
Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter trial. Eur J Cancer Clin Oncol 1989;25:1817-21. [link]
143 - Dellemijn PLI (1994)
Dellemijn PLI, Verbiest HBC, Vliet JJ van, et al. Medical therapy of malignant nerve pain. A randomized doubleblind explanatory trial with naproxen versus slow-release morphine. Eur J Cancer 1994;30A:1244- 50. [link]
144 - Derry S (2017)
Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB, McIntyre M, Wee B. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev 2017; 7: CD012638. [link]
145 - Devine EC (2003)
Devine EC. Meta-analysis of the effect of psychoeducational interventions on pain in adults with cancer. Oncol Nurs Forum 2003; 30: 75. [link]
146 - Dijkstra S (1994)
Dijkstra S, Wiggers T, Geel BN van, et al. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures. Eur J Surg 1994;160:535-42. [link]
147 - Dimitriou V (1999)
Dimitriou V, Voyagis GS. Opioid-induced pruritus: repeated vs single dose ondansetron administration in preventing pruritus after intrathecal morphine. Br J Anaesthesiol 1999;83:822-3. [link]
148 - Djulbegovic B (2002)
Djulbegovic B, Wheatly K, Ross J, Clark O, Bos G, Goldschmidt H, et al. Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev 2002, CD003188. [link]
149 - Dongen RTM van (1999)
Dongen RTM van, Crul BJP, Egmond J von. Intrathecal coadministration of bupivacaine diminishes morphine dose progression during longterm intrathecal infusion in cancer patients. Clin J Pain 1999; 15: 166-72. [link]
150 - Donner B (1996)
Donner B, Zenz M, Tryba M, et al. Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain. Pain 1996;64:527-34. [link]
151 - Drexel H (1989)
Drexel H, Dzien A, Spiegel RW, et al. Treatment of severe cancer pain by low-dose continuous subcutaneous morphine. Pain 1989;36:169-71. [link]
152 - Duarte Souza JF (2007)
Duarte Souza JF, Lajolo PP, Pinczowski H, del Giglio A. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. Support Care Cancer 2007; 15: 1319-23. [link]
153 - Durand JP (2012)
Durand JP, Deplanque G, Montheil V, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012;23(1):200-5. [link]
154 - Eggermont A (1996)
Eggermont A, Schraffordt Koops H. Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for non-resectable extremity soft tissue sarcomas; a multicentre trial. J Clin Oncol 1996;14:2653-65. [link]
155 - Eifel PJ (2006)
Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 2006;16:177-85. [link]
156 - Eisenach JC (1995)

Eisenach JC, Pen S du, Dubois M, et al. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 1995; 61: 391-9. # 

157 - Eisenberg E (1994)
Eisenberg E, Berkey CS, Carr DB, et al. Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65. [link]
158 - Eisenberg E (1995)
Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80: 290-5. [link]
159 - Eisenberg E (2015)
Eisenberg E, Suzan E, Pud D. Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon? J Pain Symptom Manage 2015; 49(3): 632-6. [link]
160 - Eizenga WH (2006)
Eizenga WH, De Bont M, Vriezen JA, et al. METC. Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg. Huisarts en Wetenschap 2006; 49: 308-312. [link]
161 - Elleman A (1989)
Elleman A, Sjogren K, Banning E, et al. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 1989;5:291-294. [link]
162 - Ellershaw JE (2002)
Ellershaw JE, Kinder C, Aldridge J, Allison M, Smith JC. Care of the dying: is pain control compromised or enhanced by continuation of the fentanyl transdermal patch in the dying phase? J Pain Symptom Manage 2002; 24: 398-403. [link]
163 - England R (2011)
England R, Maddocks M, Manderson C, et al. How practical are transmucosal products for breakthrough cancer pain? Novel use of placebo formulations to survey user opinion. BMJ Supp & Palliat Care 2011;1:349-351. [link]
164 - Enting RH (2001)
Enting RH, Van der Rijt CCD, Wilms EB, Lieverse PJ, De Wit R, Sillevis Smitt PAE. Behandeling van pijn bij kanker met systemisch toegediende opioïden. Ned Tijdschr Geneesk 2001;145: 950-954.
165 - Enzinger PC (2003)
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52. [link]
166 - Erdine S (2003)
Erdine S, Yucel A, Celik M, et al. Transdiscal approach for hypogastric plexus block. Reg Anesth Pain Med 2003; Jul-Aug 28(4):304-8. [link]
167 - Ernst DS (2003)
Ernst DS, Tannock IF, Winguist EW, Venner PM, Reyno L, Moore MJ, et al. Randomised, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol 2003;21:3335-3342. [link]
168 - Ernst E (1994)
Ernst E, Fialka V. Ice freezes pain? A review of the clinical effectiveness of analgesic cold therapy. J Pain Symptom Manage 1994;9:56-9. [link]
169 - Erridge S (2005)
Erridge S, Gaze M, Price A. Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) 2005;17:61-7. [link]
170 - Estape J (1990)
Estape J, Vinolas N, Gonzales B, et al. Ketorolac, a new non-opioid analgesic: a double-blind trial versus pentazocine in cancer pain. J Int Med Res 1990;18:298-304. [link]
171 - European Medicines Agency (2013)

European Medicines Agency. Assessment report for Instanyl. Procedure No. EMEA/H/C/959. London, 2009. European Oncology Nursing Society. EONS breakthrough pain guidelines (2013): [link]

172 - Fainsinger RL (2010)
Fainsinger RL, Nekolaichuk C, Lawlor P, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010; 46(16): 2896-904. [link]
173 - Falkmer U (2003)
Falkmer U, Jarhult J, Wersall P, et al. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 2003;42:620-33. [link]
174 - Fallon M (2011)
Fallon M, Reale C, Davies A, et al. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study. The Journal of Supportive Oncology 2011;9(6):224-31. [link]
175 - Farrar JT (1998)
Farrar JT, Cleary J, Rauck R, et al. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998;90(8):611- 6. [link]
176 - Farrar JT (2000)
Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain 2000;88(3):287-94. [link]
177 - Fassoulaki A (2001)
Fassoulaki A, Sarantopoulos C, Melemeni A, et al. Regional block and mexiletine: the effect on pain after cancer breast surgery. Regional anesthesia and pain medicine 2001;26(3):223-8. [link]
178 - Federatie Medisch Specialisten (2017)
Federatie Medisch Specialisten. leidraad ‘Overdracht van medicatiegegevens in de keten’. Federatie Medisch Specialisten, 2017.
179 - Fellowes D (2004)
Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev 2004; (2): CD002287. [link]
180 - Ferrell B (1989)
Ferrell B, Wisdom C, Wenzl C, et al. Effects of controlled released morphine on quality of life for cancer pain. Oncology Nursing Forum 1989;16(4):521–6. [link]
181 - Ferrell BR (1993)
Ferrell BR, Rhiner M, Rivera LM. Development and evaluation of the family pain questionnaire. Journal of Psychosocial Oncology 1993;10(4):21-35.
182 - Ferrer-Brechner T (1984)
Ferrer-Brechner T, Ganz P. Combination therapy with ibuprofen and methadone for chronic cancer pain. Am J Med 1984; 77: 78-83. [link]
183 - Feuer D (2000)
Feuer D, Broadley K. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database of Systematic Reviews 2000, issue 3, Art.No: CD002764. [link]
184 - Fietkau R (1991)
Fietkau R, Sauer R. Future prospects of radiotherapy in pancreatic cancer. Eur J Surg Oncol 1991;17:201-10. [link]
185 - Fine PG (2001)
Fine PG. Opioïd analgesic drugs in older people. Clin Geriatr Med 2001; Aug;17: 479–487. [link]
186 - Fine PG (2004)
Fine PG. Pharmacological management of persistent pain in older patiënts. Clin J Pain 2004; 20: 220–226. [link]
187 - Finlay I (2005)
Finlay I, Mason M, Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review.Lancet Oncol 2005;6:392-400. [link]
188 - Finnerup NB (2016)
Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; Aug;157(8):1599-1606. [link]
189 - Finnerup NB (2015)
Finnerup NB, Haroutounian S, McNil E, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Oncol 2015;Feb;14(2):162-73. [link]
190 - Fishbain DA (2009)
Fishbain DA, Cole B, Lewis LE, et al. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Medicine 2009;Aug;10(5):829-39. [link]
191 - Fisher B (1999)
Fisher B, Perera F, Kocha W. Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer. Int J Rad Onc Biol Phys 1999;45:291-5. [link]
192 - Fjellner B (1984)
Fjellner B, Hagermark O. The influence of the opiate antagonist naloxone on experimental pruritus. Acta Derm Venerol 1984;64:73-5. [link]
193 - Flock P (2003)
Flock P. Pilot study to determine the effectiveness of diamorphine gel to controle pressure ulcers pain. J Pain Symptom Manage 2003; 25: 547-554. [link]
194 - Fourney D (2001)
Fourney D, Bi-Said D. Use of pedicle screw fixation in the management of malignant spinal disease: experience in 100 consecutive procedures. J Neurosurg 2001;94(1 Suppl):25-37. [link]
195 - Fourney D (2003)
Fourney D, Schomer D. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003;98(1 Suppl):21-30. [link]
196 - Fourney D (2003)
Fourney D, York J. Management of atlantoaxial metastases with posterior occipitocervical stabilization. J Neurosurg 2003;98(2 Suppl):165-70. [link]
197 - France BD (2014)
France BD, Lewis RA, Sharma ML, Poolman M. Cordotomy in mesothelioma-related pain: a systematic review. BMJ Support Palliat Care 2014; 4(1): 19-29. [link]
198 - Frankel HL (1969)
Frankel HL, Hancock DO, Hyslop G, et al. The value of postual reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969;7:179-92. [link]
199 - Fraser A (1993)
Fraser A, Dobbs HJ, Ebbs SR, et al. Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. Br J Cancer 1993;67:402-6. [link]
200 - Fuccella LM (1975)
Fuccella LM, Conti F, Corvi G, et al. Double-blind study of the analgesic effect of indoprofen (K 4277). Clin Pharmacol Ther 1975; 17: 277-83. [link]
201 - Gabrail NY (2004)
Gabrail NY, Dvergsten C, Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 2004;20: 911–918. [link]
202 - Gadsby JG (1997)
Gadsby JG, Franks A, Jarvis P, Dewhurst F. Acupuncture like transcutaneous electrical nerve stimulation within palliative care: a pilot study. Complement Ther Med 1997; 5:13-8.
203 - Gaertner J (2012)
Gaertner J, Ruberg K, Schlesiger G, et al. Drug interactions in palliative care–it’s more than cytochrome P450. Palliative Med 2012;26(6):813-25. [link]
204 - Galluci M (1992)
Galluci M, Toscani F, Mapelli A, et al. Nimesulide in the treatment of advanced cancer pain. Double-blind comparison with naproxen. Arzneimittelforschung 1992;Aug;42:1028-30. [link]
205 - Gao L (2014)
Gao L, Yang YJ, Xu HY, et al. A randomized clinical trial of nerve block to manage end-stage pancreatic cancerous pain. Tumour biology: J Int Soc Oncodevelopmental Biol Med 2014; 35: 2297-301. [link]
206 - Garassino MC (2013)
Garassino MC, Piva S, La VN, et al. Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PLoS ONE [Electronic Resource] 2013;8(4):e59981. [link]
207 - Gardiner C (2010)
Gardiner C, Gott M, Payne S, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature. Respir Med 2010;Feb;104(2):159-65. [link]
208 - Geels P (2000)
Geels P, Eisenhauer E, Bezjak A, et al. Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 2000;18:2395-405. [link]
209 - Georges JJ (2005)
Georges JJ , Onwuteaka-Philipsen BD, Heide A van der, et al. Symptoms, treatment and ‘dying peacefully’ in terminal ill cancer patients: a prospective study. Support Care Cancer 2005;13:160-8. [link]
210 - Gerszten P (2005)
Gerszten P, Germanwala A. Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J Neurosurg Spine 2005;3:296-301. [link]
211 - Geytenbeek J (2002)
Geytenbeek J. Evidence for effective hydrotherapy. Physiotherapy 2002;88:514-29.
212 - Gibson SJ (2004)
Gibson SJ, Farrell M. A review of age differences in the neurophysiology of nociception and the perceptual experience of pain. Clin J Pain 2004;20:227-39. [link]
213 - Given CW (2001)
Given CW, Given B, Azzouz F, et al. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage 2001;Jun,21:456-66. [link]
214 - Glimelius B (1997)
Glimelius B, Ekström K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997;8:163-8. [link]
215 - Glimelius B (1996)
Glimelius B, Hoffmann K, Sjöden PO, et al. Chemotherapy improves quality of life in advance pancreatic and biliairy cancer. Ann Oncol 1996;7:593-600. [link]
216 - Gloth FM (2000)
Gloth FM, 3rd. Geriatric pain. Factors that limit pain relief and increase complications. Geriatrics 2000;55:46- 8,51-4. [link]
217 - Glover J (1995)
Glover J, Dibble SL, Dodd MJ, Miakowski C. Mood states of oncology outpatients: does pain make a difference? J Pain Symptom Manage 1995;10:120-128. [link]
218 - Goetz MP (2004)
Goetz MP, Callstrom MR, Charboneau JW. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004;22:300-6. [link]
219 - Golaskan Z (1998)
Golaskan Z, York J. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 1998;89:599-609. [link]
220 - Good P (2014)
Good P, Afsharimani B, Movva R, et al. Therapeutic challenges in cancer pain management: a systematic review of methadone. J Pain Palliat Care Pharmacother 2014;28(3):197-205. [link]
221 - Gore JM (2000)
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000-6. [link]
222 - Gosney MA (2005)
Gosney MA. Clinical assessment of elderly people with cancer. Lancet Oncol 2005;6:790-7. [link]
223 - Götrick B (2004)
Götrick B, Akerman S, Ericson D, et al. Oral pilocarpine for treatment of opioid-induced oral dryness in healthy adults. J Dent Res 2004;83:393-7. [link]
224 - Graeff A de (2006)
Graeff A de, Krol RJA. Richtlijn obstipatie. In: Graeff A de, Hesselmann GM, Krol RJA, et al. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006;b:521-36. [link]
225 - Graeff A de (2006)
Graeff A de, Kuyper MB, Hesselmann GM. Richtlijn misselijkheid en braken. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006;a:461-85. [link]
226 - Graeff A de (2006)
Graeff A de, Taphoorn MJB, Lindeman E, et al. Richtlijn dwarslaesie. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg: richtlijnen voor de praktijk. Utrecht: VIKC, januari 2006:235-51.
227 - Graeff A de (2006)
Graeff A de, Verhagen EH, Besse TC, et al. Richtlijn pijn. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg: richtlijnen voor de praktijk. Utrecht: Vereniging van Integrale Kankercentra, 2006:565-621. [link]
228 - Granata R (2014)
Granata R, Bossi P, Bertulli R, et al. Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse. Pain Med 2014;15:758-761. [link]
229 - Greenberg HS (1980)
Greenberg HS, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurology 1980;8:361-6. [link]
230 - Grond S (1996)
Grond S, Zech D, Diefenbach C et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996; 64: 107-114. [link]
231 - Grond S (1991)
Grond S, Zech D, Schug SA, et al. Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 1991;6:411-22. [link]
232 - Grunhagen D (2006)
Grunhagen D, Wilt J de. Technology Insight: utility of TNF-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities. Nature Clin Practice Oncol 2006;3:94-103. [link]
233 - Gurkan Y (2002)
Gurkan Y, Toker K. Prophylactic ondansetron reduces the incidence of intrathecal fentanyl-induced pruritus. Anesthesia Analgesia 2002;Dec;95(6):1763-6. [link]
234 - Hadley G (2013)
Hadley G, Derry S, Moore RA, et al. Transdermal fentanyl for cancer pain. [Review]. Cochrane Database Syst Rev 2013;10:CD010270. [link]
235 - Hagen N (1997)
Hagen N, Swanson R. Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid admini-stration: Treatment strategies. J Pain Symptom Manage 1997;Jul;14(1):51-8. [link]
236 - Hagen NA (1997)
Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 1997;79:1428–1437. [link]
237 - Hamza MA (1999)
Hamza MA, White PF, Ahmed HE, Ghoname EA. Effect of the frequency of transcutaneous electrical nerve stimulation on the postoperative opioid analgesic requirement and recovery profile. Anesthesiology 1999 Nov;91(5):1232-8. [link]
238 - Han S (2002)
Han S, de Klerk J. The PLACORHEN study; a double-blind, placebo-controlled, randomized radionuclide studey with (186)Re-etidronate in hormone-resistent prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study. J Nucl Med 2002;43:1150-6. [link]
239 - Hanks GW (2001)
Hanks GW, De Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;Mar 2;84(5):587-593. [link]
240 - Hanks GW (1983)
Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer--a prospective analysis of current practice. Postgraduate Med J 1983;59:702-6. [link]
241 - Hanna M (2008)
Hanna M, Thipphawong J, the 118 study group. A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain. BMC Palliat Care 2008;7:17.
242 - Hanna M (2011)
Hanna M. The effects of liver impairment on opioids used to relieve pain in cancer pain. Palliat Med 2011;Jul:25(5):604-605. [link]
243 - Hardy J (2002)
Hardy J, Daly S, McQuade B, et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Supp Care Cancer 2002;10:231-6. [link]
244 - Hardy J (2012)
Hardy J, Quinn S, Fazekas B, et al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. Journal of clinical oncology 2012;30(29):3611-7. [link]
245 - Hardy JR (2001)
Hardy JR, Rees E, Ling J, et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001;15:3-8. [link]
246 - Harrington KD (1986)
Harrington KD. Metastatic disease of the spine. J Bone Joint Surg Am 1986;68:1110-5. [link]
247 - Harris JD (2006)
Harris JD, Kotob F. Management of opioid-related side effects. In: Leon-Casasola O de (ed). Cancer pain: Pharmacological, interventional and palliative care approaches – 1st ed. 2006:207-30.
248 - Harris JT (2003)
Harris JT, Suresh Kumar K, Rajagopal MR. Intravenous morphine for rapid control of severe cancer pain. Palliat Med 2003;Apr;17(3):248-256. [link]
249 - Hartsell WF (2005)
Hartsell WF, Konski AA, Scott CB, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005;97:798-804. [link]
250 - Hassenbusch SJ (2002)
Hassenbusch SJ, Gunes S, Wachsman S, et al. Intrathecal clonidine in the treatment of intractable pain: A phase I/II study. Pain Med 2002;3:85-91. [link]
251 - Hayek SM (2011)
Hayek SM, Deer TR, Pope JE, et al. Intrathecal therapy for cancer and non-cancer pain. Pain Physician. 2011;May-Jun;14(3):219-48. [link]
252 - Heiskanen T (1997)
Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37–45. [link]
253 - Heiskanen T (2009)
Heiskanen T, Mätzke S, Haakana S, Gergov M, Vuori E, Kalso E. Transdermal fentanyl in cachectic cancer patients. Pain 2009; 144(1-2): 218-22. [link]
254 - Heiskanen TE (2000)
Heiskanen TE, Ruismaki PM, Seppala TA, et al. Morphine or oxycodone in cancer pain? Acta Oncologica 2000;39(8):941–7.
255 - Henke CC (2014)
Henke CC, Cabri J, Fricke L, et al. Strength and endurance training in the treatment of lung cancer patiënts in stages IIIA/IIIB/IV. Supp Care Cancer 2014;Jan;22(1):95-101. [link]
256 - Hermens JM (1985)
Hermens JM, Ebertz JM, Hanifin JM. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. Anesthesiology 1985;62:124-9. [link]
257 - Higginson I (1990)
Higginson I, Wade A, McCarthy M. Palliative care: views of patients and their families. BMJ 1990;301:277-81. [link]
258 - Hillen HFP (2004)
Hillen HFP, Schouten HC. Kanker bij ouderen. Breda: Amgen BV, 2004.
259 - Hillner BE (2000)
Hillner BE, Ingle JN, Berenson JR Janjan CG, Albain KS, Lipton A, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. J Clin Oncol 2000;18:1378-1391. [link]
260 - Hillner BE (2003)
Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee G, Janjan CG, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042-4057. [link]
261 - Hird A (2009)
Hird A, Zhang L, Holt T, et al. Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study. Clinical Oncology (Royal College of Radiologists) 2009;21(4):329-35. [link]
262 - Hjermstad MJ (2011)
Hjermstad MJ, Fayers PM, Haugen DF, et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. [Review]. Journal of Pain & Symptom Management 2011;41(6):1073-93. [link]
263 - Hodson DI (1996)
Hodson DI, Bruera E, Eapen L. The role of palliative radiotherapy in advanced head and neck cancer. Can J Oncol 1996;6(Suppl 1):54-60. [link]
264 - Holman P (2005)
Holman P, Suki D. Surgical management of metastatic disease if the lumbar spine: experience with 139 patients. J Neurosurg Spine 2005;2:550-63. [link]
265 - Homs M (2004)
Homs M, Essink-Bot M, Borsboom GJ. Quality of life after palliative treatment for oesophageal cancer - a prospective comparison between stent placement and single dose brachytherapy. Eur J Cancer 2004;40:1862-71. [link]
266 - Homs M (2004)
Homs M, Steyerberg EW, Eijkenboom WM. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer. Lancet 2004;364:1497-504. [link]
267 - Houde RW (1986)
Houde RW. Clinical analgesic studies of hydromorphone. In: Foley KM and Inturrisi CE (eds) Advances in pain research and therapy. Vol. 8, New York: Raven Press 1986;pp.129–135.
268 - Hunt R (1999)
Hunt R, Fazekas B, Thorne D, et al. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 1999;18:111–119. [link]
269 - Hurlow A (2012)
Hurlow A, Bennett MI, Robb KA, et al. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults. The Cochrane Database Systematic Eev. 2012;Mar 14;(3):CD006276. [link]
270 - IASP (1994)
IASP. Task force on taxonomy. Classification of chronic pain. Seattle: IASP Press, 1994
271 - IASP (2008)
IASP. Total cancer pain, 2008. [link]
272 - IKNL/Palliactief (2017)
IKNL/Palliactief, Kwaliteitskader palliatieve zorg Nederland, 2017. [link]
273 - Imanaka K (2013)
Imanaka K, Tominaga Y, Etropolski M, et al. Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain. Current Medical Research & Opinion 2013;29(10):1399-409. [link]
274 - Imanaka K (2014)
Imanaka K, Tominaga Y, Etropolski M, et al. Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release. Clin Drug Invest 2014;34(7):501-11. [link]
275 - Imani F (2014)
Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon 2014;Oct 11;14(10):e23539 doi:10.5812 [link]
276 - Ingham JM (1998)
Ingham JM, Foley KM. Pain and the barriers to its relief at the end of life: a lesson for improving end of life health care. Hosp J 1998;13:89-100. [link]
277 - Ingram SS (2002)
Ingram SS, Seo PH, Martell RE, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 2002;20:770-5. [link]
278 - Ischia S (1984)
Ischia S, Luzzani A, Ischia A, et al. Subarachnoid neurolytic block (L5-S1) and unilateral percutaneous cervical cordotomy in the treatment of pain secondary to pelvic malignant disease. Pain. 1984;20:139-149. [link]
279 - Israel FJ (2010)
Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage 2010; 39: 548-54. [link]
280 - Jackson R (2001)
Jackson R, Loh S. Metastatic renal cell carcinoma of the spine: surgical treatment and results. J Neurosurg 2001;94(1 Suppl):18-24. [link]
281 - Jackson K (2001)
Jackson K, Ashby M, Martin P, et al. Burst ketamine for refractory cancer pain: an open-label audit of 39 patients. Journal of pain and symptom management 2001;22(4):834-42. [link]
282 - Jackson MB (1999)
Jackson MB, Pounder D, Price C, et al. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax 1999;Mar;54(3):238-41. [link]
283 - Jahn P (2014)
Jahn P, Kuss O, Schmidt H, et al. Improvement of pain-related self-management for cancer patients through a modular transitional nursing intervention: a cluster-randomized multicenter trial. Pain 2014;155(4):746- 54. [link]
284 - Jakobsson M (1999)
Jakobsson M, Strang P. Fentanyl patches for the treatment of pain in dying cancer patients. Anticancer Res. 1999;19(5C):4441-2. [link]
285 - Jameel A (1995)
Jameel A, Stein RC, Rawson NSB, et al. Comparative study of intramuscular ketorolac tromethamine and morphine in patients experiencing cancer pain. Int J Oncol 1995;6:1307-11. [link]
286 - Jandhyala R (2012)
Jandhyala R, Fullarton J. Various formulations of oral transmucosal fentanyl for breakthrough cancer pain: an indirect mixed treatment comparison meta-analysis. BMJ supportive & palliative care 2012;2(2):156-62. [link]
287 - Jandhyala R (2013)
Jandhyala R, Fullarton JR, Bennett MI. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials. Journal of Pain & Symptom Management 2013;46(4):573-80. [link]
288 - Jane SW (2011)
Jane SW, Chen SL, Wilkie DJ, et al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patiënts with metastatic bone pain: a randomized clinical trial. Pain 2011;Oct;152: 2432-42. [link]
289 - Jansen K (2018)
Jansen K, Haugen DF, Pont L, Ruths S. Safety and effectiveness of palliative drug treatment in the last days of life-A systematic literature review. J Pain Symptom Manage. 2018 Feb;55(2):508-521. [link]
290 - Jansman FGA (2008)
Jansman FGA. 19 februari 2008.
291 - Janssen DJ (2008)
Janssen DJ, Spruit MA, Wouters EF et al. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliative Medicine 2008;Dec;22(8),938-948. [link]
292 - Jenkins CA (1999)
Jenkins CA, Bruera E. Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients. Palliat Med 1999;13:183-6. [link]
293 - Jensen MP (2003)
Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain. 2003;4(1):2-21. [link]
294 - Jensen W (2014)
Jensen W, Baumann FT, Stein A, et al. Exercise training in patiënts with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study. Supp Care Cancer 2014; Jul;22(7):1797-806. [link]
295 - Johansson K (1999)
Johansson K, Albertsson M, Ingvar C, et al. Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema. Lymphology 1999;32:103-10. [link]
296 - Johnson CD (2009)
Johnson CD, Berry DP, Harris S, et al. An open randomized comparison of clinical effectiveness of protocol-driven opioid analgesia, celiac plexus block or thoracoscopic splanchnicectomy for pain management in patients with pancreatic and other abdominal malignancies. Pancreatology 2009; 9: 755-63. 10.1159/000199441. [link]
297 - Johnson JR (2013)
Johnson JR, Lossignol D, Burnell-Nugent M, et al. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. Journal of Pain & Symptom Management 2013;46(2):207-18. [link]
298 - Johnson JR (1994)
Johnson JR, Miller AJ. The efficay of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study. Palliat Med 1994;8:129-35. [link]
299 - Jones B (2003)
Jones B, Finlay I, Ray A, et al. Is there still a role for open cordotomy in cancer pain management? J Pain Symptom Manage 2003;25:179-84. [link]
300 - Jones RD (2000)
Jones RD, Miles W, Prankerd R, et al. Tenoxicam i.v. in major gynaecological surgery-pharmacokinetic, pain relief and haematological effects. Anaesth Intensive Care 2000;Oct;28(5):491-500. [link]
301 - Jongen JL (2013)
Jongen JL, Huijsman ML, Jessurun J, et al. The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. [Review]. Journal of Pain & Symptom Management 2013;46(4):581-90. [link]
302 - Joshi M (2012)
Joshi M, Joshi A, Bartter T. Symptom burden in chronic obstructive pulmonary disease and cancer. Curr Opin Pulm Med 2012;Mar;18(2):97-103. [link]
303 - Kaasaa S (2006)
Kaasaa S, Brenne E, Lundab JA. Prospective randomised multicenter trial on single fraction radiotherapy (8Gyx1) versus multiple fractions (3Gyx10) in the treatment of painful bone metastases. Radiother Oncol 2006;79:278-84. [link]
304 - Kabel JS (2006)
Kabel JS. Neuropsychiatrische bijwerkingen door tramadol. Pharm Weekblad 2006;18: 611-613. [link]
305 - Kalso E (1990)
Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clinical Pharmacology and Therapeutics 1990;47(5):639–46. [link]
306 - Kalso E (2004)
Kalso E, Edwards JE, Moore A, et al. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain 2004;112:372-80. [link]
307 - Kamat A (2003)
Kamat A, Huang S. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol 2003;170:1868-71. [link]
308 - Katcher J (1999)
Katcher J, Walsh D. Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. J Pain Symptom Manage 1999;17:70-2. [link]
309 - Kautio AL (2008)
Kautio AL, Haanpaa M, Saarto T, et al. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. Journal of Pain & Symptom Management 2008;35(1):31-9. [link]
310 - Kawamata M (1996)
Kawamata M, Ishitani K, Ishikawa K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996;Mar;64(3): 597-602. [link]
311 - Keefe FJ (2005)
Keefe FJ, Ahles TA, Sutton L, et al. Partner-guided cancer pain management at the end of life: a preliminary study. J Pain Symptom Manage 2005;29:263-72. [link]
312 - Keefe FJ (2003)
Keefe FJ, Ahles TA, et al. The self-efficacy of family caregivers for helping cancer patients manage pain at end-oflife. Pain 2003;103:157-62. [link]
313 - Khiewkhern S (2013)
Khiewkhern S, Promthet S, Sukprasert A, Eunhpinitpong W, Bradshaw P. Effectiveness of aromatherapy with light thai massage for cellular immunity improvement in colorectal cancer patiënts receiving chemotherapy. Asian Pac J Cancer Prev 2013; 14(6): 3903–7. [link]
314 - Khojainova N (2002)
Khojainova N, Santiago-Palma J, Kornick C, et al. Olanzapine in the management of cancer pain. J Pain Symptom Manage 2002; 23: 346-350. [link]
315 - Kim HS (2013)
Kim HS, Shin SJ, Kim SC, et al. Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors. Support Care Cancer. 2013 Jun;21(6):1751-9. [link]
316 - Kim JE (2004)
Kim JE, Dodd M, West C, et al. The PRO-SELF pain control program improves patients' knowledge of cancer pain management. Oncol Nurs Forum. 2004 Nov 16;31(6):1137-43. [link]
317 - King SJ (2011)
King SJ, Reid C, Forbes K, et al. A systematic review of oxycodone in the management of cancer pain. [Review]. Palliative Med 2011;Jul;25(5):454-70. [link]
318 - Kjellberg F (2001)
Kjellberg F, Tramer MR. Pharmacological control of opioid-induced pruritis: a quantitative systematic review of randomized trials. Eur J Anaesthesiol 2001;Jun;18(6):346-57. [link]
319 - Klepstad P (2011)
Klepstad P, Kaasa S, Borchgrevink PC. Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic review. Palliat Med 2011;Jul;25(5): 424-30. [link]
320 - Klepstad P (2003)
Klepstad P, Kaasa S, Jystad A, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain 2003; Jan;101(1-2):193-198. [link]
321 - Klepstad P (2015)
Klepstad P, Kurita GP, Mercadante S, Sjøgren P: Evidence of peripheral nerve blocks for cancer-related pain: a systematic review. Minerva Anestesiol. 2015;Jul;81(7):789-93. [link]
322 - Koller A (2013)
Koller A, Miaskowski C, De GS, et al. Results of a randomized controlled pilot study of a self-management intervention for cancer pain. European Journal of Oncology Nursing 2013;17(3):284-91. [link]
323 - Kolotas C (2003)
Kolotas C, Roddiger S, Strassman G. Palliative interstital HDR brachytherapy for recurrent rectal cancer. Implantation techniques and results. Strahlenther Onkol 2003;179:458-63. [link]
324 - Kong VK (2009)
Kong VK, Irwin MG. Adjuvant analgesics in neuropathic pain. Eur J Anaesthesiol 2009;26:96-100. [link]
325 - Koppert W (2005)
Koppert W, Ihmsen H, Korber N, et al. Different profiles of buprenophine induced analgesia and antihyperalgesia in a human pain model. Pain 2005;Nov;118(1-2):15-22. [link]
326 - Kose KC (2006)
Kose KC, Cabesoy O, Akan B, et al. Functional results of vertebral augmentation techniques in pathological vertebral fractures of myelomatous patients. J Natl Med Assoc 2006;98:1654-8. [link]
327 - Kosugi T (2014)
Kosugi T, Hamada S, Takigawa C, et al. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients. J Pain Symptom Manage. 2014 Jun;47(6):990-1000. [link]
328 - Koswig S (1999)
Koswig S, Budach V. [Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study]. Strahlenther Onkol 1999;175:500-8. [link]
329 - Kotlinska-Lemieszek A (2012)
Kotlinska-Lemieszek A, Deskur-Smielecka E, Zaporowska-Stachowiak I. Polytherapy in patients with advanced cancer-the importance of pharmacokinetic interactions. Palliative Med 2012;26(4):579-80.
330 - Kottenberg-Assenmacher E (1999)
Kottenberg-Assenmacher E, Peters J. [Mechanisms of tachyphylaxis in regional anesthesia of long duration]. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:733-42. [link]
331 - Koyyalagunta D (2012)
Koyyalagunta D, Bruera E, Solanki DR, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. [Review]. Pain Phys 2012;15(3:Suppl):Suppl-58. [link]
332 - Kramer GW (2005)
Kramer GW, Wanders SL, Noordijk EM. Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol 2005;22:2962-70. [link]
333 - Kravitz RL (2011)
Kravitz RL, Tancredi DJ, Grennan T, et al. Cancer Health Empowerment for Living without Pain (Ca-HELP): effects of a tailored education and coaching intervention on pain and impairment. Pain 2011;152(7):1572-82. [link]
334 - Kravitz RL (2012)
Kravitz RL, Tancredi DJ, Jerant A, et al. Influence of patient coaching on analgesic treatment adjustment: secondary analysis of a randomized controlled trial.J Pain Symptom Manage. 2012 May;43(5):874-84. [link]
335 - Kress HG (2014)
Kress HG, Koch ED, Kosturski H, et al. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain. Pain Phys 2014;17(4):329-43 [link]
336 - Kress HG (2009)
Kress HG, Oronska A, Kaczmarek Z, et al. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Clin Ther 2009;31(6):1177-91. [link]
337 - Kress HG (2008)
Kress HG, Von der Laage D, Hoerauf KH, et al. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain. Journal of Pain and Symptom Management 2008;36(3):268–79. [link]
338 - Kroll CE (2014)
Kroll CE, Schartz B, Gonzalez-Fernandez M, Gordon AH, Babade M, Erdek MA, Mekhail N, Cohen SP. Factors associated with outcome after superior hypogastric plexus neurolysis in cancer patients. Clin J Pain 2014;Jan;30(1):55-62. doi:10.1097/AJP. [link]
339 - Kumar A (2001)
Kumar A, Tripathi SS, Dhar D, et al. A case of reversible paraparesis following celiac plexus block. Reg Anesth Pain Med 2001;26:75-8. [link]
340 - Kuo KL (2013)
Kuo KL, Saokaew S, Stenehjem DD. The pharmacoeconomics of breakthrough cancer pain. [Review]. Journal of Pain & Palliative Care Pharmacotherapy 2013;27(2):167-75. [link]
341 - Kurita GP (2015)
Kurita GP, Benthien KS, Nordly M, et al. The evidence of neuraxial administration of analgesics for cancer-related pain: a systematic review. Acta Anaesthesiol Scandinavica 2015;Oct;59(9):1103-15. 10.1111/aas.12485. [link]
342 - Kurita GP (2011)
Kurita GP, Kaasa S, Sjogren P. Spinal opioids in adult patients with cancer pain: a systematic review: a European Palliative Care Research Collaborative (EPCRC) opioid guidelines project. Palliat Med 2011;Jul;25(5):560-77. 10.1177/0269216310386279. [link]
343 - Kutner JS (2008)
Kutner JS, Smith MC, Corbin L, et al. Massage therapy versus simple touch to improve pain and mood in patiënts with advanced cancer: a randomized trial. Annals Int Med 2008;Sep 16;149(6):369-79.  [link]
344 - Kwaliteitsinstituut voor de gezondheidszorg CBO (2002)
Kwaliteitsinstituut voor de gezondheidszorg CBO. Lymfeoedeem. Alphen a/d Rijn: Van Zuiden Communications, 2002.
345 - Kwaliteitsinstituut voor de gezondheidszorg CBO (2003)
Kwaliteitsinstituut voor de Gezondheidszorg CBO. Richtlijn NSAID-gebruik en preventie van maagschade, 2003.
346 - Kwekkeboom KL (2012)
Kwekkeboom KL, Abbott-Anderson K, Cherwin C, et al. Pilot randomized controlled trial of a patient-controlled cognitive-behavioral intervention for the pain, fatigue, and sleep disturbance symptom cluster in cancer. J Pain Symptom Manage 2012;Dec;44(6): 810-22. [link]
347 - Kwekkeboom KL (2010)
Kwekkeboom KL, Cherwin CH, Lee JW, Wanta B. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage 2010;Jan;39(1):126-38. [link]
348 - Kwekkeboom KL (2003)
Kwekkeboom KL, Kneip J, Pearson L. A pilot study to predict success with guided imagery for cancer pain. Pain Manage Nurs 2003;Sep;4(3):112-23. [link]
349 - Kylmala T (1993)
Kylmala T, Tammela T, Risteli L, et al. Evaluation of the effect of oral clodronate on skeletal metastases with type I collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. Eur J Cancer 1993; 29A: 821-825. [link]
350 - Kylmala T (1997)
Kylmala T, Taube T, Tammela TL. Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer. Br J Cancer 1997;76(7):939-42. [link]
351 - Kyriakides K (1999)
Kyriakides K, Hussain SK, Hobbs GJ, Management of opioid-induced pruritus: a role for 5-HT3 antagonists? Br J Anesthesiol 1999;Mar;82(3):439-41. [link]
352 - Lai YH (2004)
Lai YH, Guo SL, Keefe FJ, et al. Effects of brief pain education on hospitalized cancer patients with moderate to severe pain. Support Care Cancer. 2004 Sep;12(9):645-52. [link]
353 - Landi F (2001)
Landi F, Onder G, Cesari M, et al. Pain management in frail, community-living elderly patients. Arch Intern Med 2001;161:2721-4. [link]
354 - Laugsand EA (2011)
Laugsand EA, Kaasa S, Klepstad P. Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med. 2011;Jul;25(5):442-53. [link]
355 - Launay-Vacher V (2005)
Launay-Vacher V, Karie S, Fau JB, et al. Treatment of pain in patients with renal insufficiency: the World Health Organization three-step ladder adapted. J Pain 2005;Mar;6(3):137-48. [link]
356 - Lauretti GR (1999)
Lauretti GR, Lima IC, Reis MP, et al. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 1999;90(6):1528-33. [link]
357 - Lauretti GR (2003)
Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. British Journal of Cancer 2003;89(11):2027–30. [link]
358 - Lawlor PG (2000)
Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000;160:786-94. [link]
359 - LeBon B (2009)
LeBon B, Zeppetella G, Higginson IJ. Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage 2009;May;37(5):913-917. [link]
360 - Lee M (2011)
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;Mar-Apr;14(2):145-61. [link]
361 - Lee SH (2015)
Lee SH, Kim JY, Yeo S, et al. Meta-Analysis of Massage Therapy on Cancer Pain. Integr Cancer Ther 2015;Jul;14(4):297-304. [link]
362 - Lefebvre JL (2006)
Lefebvre JL. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 2006;7:747-55. [link]
363 - Legeby M (2005)
Legeby M, Sandelin K, Wickman M, et al. Analgesic efficacy of diclofenac in combination with morphine and paracetamol after mastectomy and immediate breast reconstruction. Acta Anaesthesiol Scan 2005;49:1360-6. [link]
364 - Leon Casasola OA de (1993)
Leon Casasola OA de, Kent E, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain 1993; Aug;54(2):145-51. [link]
365 - Levy MH (2005)
Levy MH, Samuel TA. Management of cancer pain. Semin Oncol 2005;Apr; 32:179-193. [link]
366 - Lewington V (1991)
Lewington V, McEwan A. A prospective, randomized double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer 1991;27:954-8. [link]
367 - Li C (2003)
Li C, Chao Y, Chi K. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Rad Onc Biol Phys 2003;57:98-104. [link]
368 - Lichter I (1990)
Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990;6:7-15. [link]
369 - Lillemoe KD (1993)
Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993;May; 217: 447-55. [link]
370 - Lin CC (2006)
Lin CC, Chou PL, Wu SL, et al. Long-term effectiveness of a patient and family pain education program on overcoming barriers to management of cancer pain. Pain 2006;122(3):271-81. Epub 2006 Mar 20. [link]
371 - Linden YM van der (2004)
Linden YM van der, Dijkstra PD, Kroon HM, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. Results based on a randomised trial of radiotherapy. J Bone Joint Surg Br 2004;May;86(4):566-73. [link]
372 - Linden YM van der (2005)
Linden YM van der, Dijkstra PDS, Vonk EJA, et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-8. [link]
373 - Linden YM van der (2003)
Linden YM van der, Kroon HM, Dijkstra PD, et al. Simple radiographic parameter predicts fracturing in metastatic femoral bone lesions: results from a randomized trial. Radiother Oncol 2003;69:21-31. [link]
374 - Lingareddy V (1997)
Lingareddy V, Ahmad N, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Rad Onc Biol Phys 1997;38:785-90. [link]
375 - Listing M (2009)
Listing M, Reisshauer A, Krohn M, et al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer. Psychooncology 2009;Dec; 18(12): 1290–9. [link]
376 - Litterini AJ (2013)
Litterini AJ, Fieler VK, Cavanaugh JT, Lee JQ. Differential effects of cardiovascular and resistance exercise on functional mobility in individuals with advanced cancer: a randomized trial. Archives Phys Med Rehab 2013;Dec; 94: 2329-35. [link]
377 - Loeser JD (1999)
Loeser JD, Melzack R. Pain: an overview. The Lancet 1999: 1607-1609. [link]
378 - Loeser JD (1989)
Loeser JD. Chronic pain. In Seitz FC, JCarr JE, Covey M (Eds.): Issues in behavioral medicine. Bozema, MT: Clinical Management Consultants, 1989, pp. 16-20.
379 - Lomen PL (1986)
Lomen PL, Samal BA, Lamborn KR, et al. Flurbiprofen for the treatment of bone pain in patients with metastatic breast cancer. Am J Med 1986 Mar; 24;80(3A):83-7. [link]
380 - Lopez-Saca JM (2013)
Lopez-Saca JM, Lopez Guzman J, Centena C. A systematic review of the influence of opioids on advanced cancer patient survival. Curr Opin Support Palliat Care. 2013 Dec;7(4):424-30. [link]
381 - Lovell MR (2010)
Lovell MR, Forder PM, Stockler MR, et al. A randomized controlled trial of a standardized educational intervention for patients with cancer pain. J Pain Symptom Manage 2010;40(1):49-59. [link]
382 - Luebbert K (2001)
Luebbert K, Dahme B, Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta- analytical review. Psychooncology 2001;Nov-dec; 10: 490-502. [link]
383 - Luo J (2003)
Luo J, Wang H, Wang H, et al. Treatment of moderate and severe cancer pain by lornoxicam: 32 cases report. Chin J Clin Rehab 2003;7:656-7.
384 - Lussier D (2004)
Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004;9:571-91 [link]
385 - Lynn J (2003)
Lynn J, Adamson DM. Living Well at the End of Life. Adapting health care to serious chronic illness in old age. RAND Health, Santa Monica: 2003.
386 - Macbeth F (2001)
Macbeth F, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2001;CD002143 [link]
387 - Maddocks I (1996)
Maddocks I, Somogyi A, Abbott F, et al. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 1996;Sep;12:182-9. [link]
388 - Mahmoud SM (2014)
Mahmoud SM. The effect of systemic steroids on the incidence of bone pain flare with palliative Irradiation. Middle East J Cancer 2014;5(2):83-9.
389 - Maltoni M (2005)
Maltoni M, Scarpi E, Modonesi C et al. A validation study of the WHO analgesic ladder : a two-step vs three-step strategy. Supp Care Cancer 2005;Nov; 13: 888-894. [link]
390 - Mancini R (2012)
Mancini R. Implementing a Standardized Pharmacist Assessment and Evaluating the Role of a Pharmacist in a Multidisciplinary Supportive Oncology Clinic. J Supportive Oncol 2012;10(3):99-106. [link]
391 - Mannaerts G (2001)
Mannaerts G, Martijn H, Rutten H. Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal cancer and local recurrence. Ned Tijdschr Geneeskd 2001;145:1460-6. [link]
392 - Mannix K (2000)
Mannix K, Ahmedzai SH, Anderson H, Lloyd-Williams M, Wilcock A. Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care. Pall Med 2000;14:455-461. [link]
393 - Marinangeli F (2004)
Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, Porzio G, Marchetti P, Varrassi G. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 2004;May; 27: 409-16. [link]
394 - Martino G (1978)
Martino G, Emanueli A, Mandelli V, et al. A controlled study of the analgesic effect of two non-steroidal antiinflammatory drugs in cancer pain. Arzneimittelforschung 1978; 28: 1657-9. [link]
395 - Martino G (1976)
Martino G, Ventafridda V, Parini J, et al. A controlled study of the analgesic activity of indoprofen in patients with cancer pain. In: Bonica JJ, Albe-Fessard D (eds). Pharmacological agents in chronic pain, Vol 1, Advances in pain research and therapy. New York: Raven Press, 1976: 573-8.
396 - Maurer PM (1993)
Maurer PM, Bartkowski RR. Drug interactions of clinical significance with opioid analgesics. Drug Safety 1993;8(1):30-48. [link]
397 - Maxon H (1991)
Maxon H, Schroder L. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a couble-blind crossover comparison with placebo. J Nucl Med 1991;32:1877-81. [link]
398 - McCaffery (1968)
McCaffery, M. Nursing practice theories related to cognition, bodily pain, and man-environment interactions. University of California at Los Angeles Students’ Store, Los Angeles; 1968.
399 - McDonald M (1999)
McDonald M. Assessment and management of cancer pain in the cognitively impaired elderly. Geriatr Nurs 1999;Sep-Oct:;20: 249-54. [link]
400 - McDonald P (1991)
McDonald P, Graham P, Clayton M, et al. Regular subcutaneous bolus morphine via an indwelling cannula for pain from advanced cancer. Palliat Med 1991;5:323-9.
401 - McNicol E (2003)
McNicol E, Horowicz-Mehler N, Fisk R, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;Jun;4:231-56. [link]
402 - McNicol E (2005)
McNicol E, Strassels S, Goudas L, et al. Nonsteroidal anti-inflammatory drugs or paracetamol, alone or combined with opioids for cancer pain. The Cochrane Database of Systematic Reviews, 2005 (2), CD005180.
403 - McNicol E (2008)
McNicol E. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J Pain Palliat Care Pharmacotherapy. 2008; 22(4): 270-81 [link]
404 - McQuay HJ (2000)
McQuay HJ, Collins SL, Carroll D. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2000;CD001793. [link]
405 - McQuay HJ (2003)
McQuay HJ, Edwards JE. Meta-analysis of single dose tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl 2003;28:19-22. [link]
406 - McWilliams K (2014)
McWilliams K, Simmons C, Laird BJ, et al. A systematic review of opioid effects on the hypogonadal axis of cancer patients. Supportive Care Cancer 2014;22(6):1699-704. [link]
407 - Mehta N (2016)
Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med. 2016;128(3):282-9. [link]
408 - Meijler WJ (2014)
Meijler WJ. Reply: a network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manage 2014;46:e9-10. [link]
409 - Melzack R (1979)
Melzack R, Mount BM, Gordon JM. The Brompton mixture versus morphine solution given orally: effects on pain. Canadian Medical Association Journal 1979;120(4): 435–8.
410 - Mercadante S (1999)
Mercadante S, Casuccio A,Agnello A, Barresi L. Methadone response in advanced cancer patients with pain followed at home. Journal of Pain and Symptom Management 1999;18(3):188–92. [link]
411 - Mercadante S (2000)
Mercadante S, Arcuri E, Tirelli W, et al. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. Journal of pain and symptom management 2000;20(4):246-52. [link]
412 - Mercadante S (2011)
Mercadante S, Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 2011;25:504-515. [link]
413 - Mercadante S (2001)
Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients. A prospective study. J Clin Oncol 2001;19:2898-904. [link]
414 - Mercadante S (2000)
Mercadante S, Casuccio A, Pumo S, et al. Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender. Support Care Cancer 2000;8(2)123-30. [link]
415 - Mercadante S (2002)
Mercadante S, Fulfaro F, Casuccio A. A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 2002; 38: 1358-63. [link]
416 - Mercadante S (2002)
Mercadante S, Fulfaro F, Casuccio A. Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block. Tumori 2002;May-Jun; 88: 243-5. [link]
417 - Mercadante S (2015)
Mercadante S, Klepstad P, Kurita GP, Sjøgren P, Giarratano A. Sympathetic blocks for visceral cancer pain management: A systematic review and EAPC recommendations. Crit Rev Oncol Hematol 2015;Dec; 96(3):577-83. [link]
418 - Mercadante S (2013)
Mercadante S, Porzio G, Aielli F, et al. The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin J Pain 2013;29(1):15-9. [link]
419 - Mercadante S (2008)
Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040–1046. [link]
420 - Mercadante S (2009)
Mercadante S, Radbruch L, Davies A, et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Current Medical Research & Opinion 2009;25(11):2805-15. [link]
421 - Mercadante S (2010)
Mercadante S, Tirelli W, David F, et al. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clinical Journal of Pain 2010;26(9):294–7. [link]
422 - Mercadante S (2007)
Mercadante S, Villari P, Ferrera P, et al. Transmucosal fentanyl vs. intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer 2007;96(12):1828-33. [link]
423 - Mercadante S (1999)
Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain 1999;Jan;79(1):1-13. [link]
424 - Mercandante S (1999)
Mercandante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer 1999;85:1849-58. [link]
425 - Mesgarpour B (2014)
Mesgarpour B, Griebler U, Glechner A, et al. Extended-release opioids in the management of cancer pain: a systematic review of efficacy and safety. European Journal of Pain 2014;18(5):605-16. [link]
426 - Metzke B (2012)
Metzke B, Hug MJ, Fink G, et al. Drug-drug interactions in the hematology and oncology department: A real-life assessment of frequency and severity. Blood 2012;120(21).
427 - Miaskowki C (1997)
Miaskowki C, Zimmer EF, Barrett KM, et al. Differences in patient’ and family caregivers’ perceptions of the pain experience influence patient and caregiver outcomes. Pain 1997;72:217-26. [link]
428 - Miaskowski C (2004)
Miaskowski C, Dodd M, West C, et al. Randomized clinical trial of the effectiveness of a self-care intervention to improve cancer pain management. Journal of Clinical Oncology 2004;22(9):1713-20. [link]
429 - Minotti V (1998)
Minotti V, Angelis V de, Righetti E, et al. Double-blind evaluation of analgesic efficacy of orally administered diclofenac, diclofenac plus codeine and diclofenac plus imipramine in chronic cancer pain. Pain 1998;Feb; 74: 133-7. [link]
430 - Minotti V (1998)
Minotti V, Betti M, Ciccarese G, et al. A double-blind study comparing two single dose regimens of ketorolac with diclofenac in pain due to cancer. Pharmacotherapy 1998;May-Jun;18(3):504-8. [link]
431 - Minotti V (1989)
Minotti V, Patoia L, Roila F, et al. Double-blind evaluation of analgesic efficacy of orally administered diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic cancer pain. Pain 1989;36:177-83. [link]
432 - Mironer YE (2002)
Mironer YE, Haasis JC, Chapple I, et al. Efficacy and safety of intrathecal opioid/bupivacaine mixture in chronic nonmalignant pain: A double blind, randomized, crossover, multicenter study by the National Forum of Independent Pain Clinicians (NFIPC). Neuromodulation 2002; 5: 208-13 . [link]
433 - Mishra S (2012)
Mishra S, Bhatnagar S, Goyal GN, et al. A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. American Journal of Hospice & Palliative Medicine 2012;29(3):177-82. [link]
434 - Mishra S (2009)
Mishra S, Bhatnagar S, Gupta S, et al. Managment of neuropathic cancer pain following WHO analgesic ladder: a prospective study. Am J Hosp Palliat Care 008 Dec-2009 Jan;25(6):447-51. doi: 10.1177/1049909108322288. [link]
435 - Mishra S (2013)
Mishra S, Bhatnagar S, Rana SP, Khurana D, Thulkar S. Efficacy of the anterior ultrasound-guided superior hypogastric plexus neurolysis in pelvic cancer pain in advanced gynecological cancer patients. Pain Med 2013; 14(6): 837-42. [link]
436 - Mithal NP (1994)
Mithal NP, Needham PR, Hoskin PJ. Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys 1994;29:1011-4. [link]
437 - Moertel CG (1971)
Moertel CG, Ahmann DL, Taylor WF, et al. Aspirin and pancreatic cancer pain. Gastroenterology 1971;Apr; 60: 552-3. [link]
438 - Moertel CG (1974)
Moertel CG, Ahmann DL, Taylor WF, et al. Relief of pain by oral medications. A controlled evaluation of analgesic combinations. JAMA 1974; 229: 55-9. Jul; 229: 55-9. [link]
439 - Mohanti BK (2004)
Mohanti BK, Umapathy H, Bahadur S. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol 2004;71:275-80. [link]
440 - Mohiuddin M (1996)
Mohiuddin M, Chen E, Ahmad N. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 1996;14:722-8. [link]
441 - Mondry TE (2004)
Mondry TE, Riffenburgh RH, Johnstone PA. Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J 2004;10:42-8. [link]
442 - Moore RA (2005)
Moore RA, McQuay H. Prevalence of opioid adverse events in chronic non-malignant pain: a systematic review of randomised trials of oral opioids. Arthritis Res Therapy 2005;7:1046-51. [link]
443 - Moore S (2002)
Moore S, Corner J, Haviland J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002;Nov 16; 325: 1-7. [link]
444 - Morganti A (2003)
Morganti A, Trodella L, Valentini V. Pain relief with short-term irradiation in locally-advanced carcinoma of the pancreas. J Palliat Care 2003;19:258-62. [link]
445 - Moriarty M (1999)
Moriarty M, McDonald CJ, Miller AJ. A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. J Clin Res 1999;2:1–8.
446 - Morita T (2005)
Morita T, Takigawa C, Onishi H, et al. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manage 2005;Jul;30:96-103. [link]
447 - Mucci-LoRusso P (1998)
Mucci-LoRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: A randomized, doubleblind, parallel-group study. European Journal of Pain 1998;2:239–49. [link]
448 - Mustafa M (2013)
Mustafa M, Carson-Stevens A, Gillespie D, Edwards Adrian GK. Psychological interventions for women with metastatic breast cancer. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD004253. DOI: 10,1002/14651858.CD004253.pub4 [link]
449 - Nagaro T (1994)
Nagaro T, Amakawa K, Yamauchi Y, et al. Percutaneous cervical cordotomy and subarachnoid phenol block using fluoroscopy in pain control of costopleural syndrome. Pain 1994;Sep; 58: 325-30. [link]
450 - Nagels W (2013)
Nagels W, Pease N, Bekkering G, et al. Celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med 2013;Aug; 14: 1140-63. [link]
451 - Nalamachu S (2011)
Nalamachu S, Hassman D, Wallace MS, et al. Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain. Current Medical Research & Opinion 2011;27(3):519-30.n [link]
452 - Nalamachu SR (2012)
Nalamachu SR, Rauck RL, Wallace MS, et al. Successful dose finding with sublingual fentanyl tablet: combined results from 2 open-label titration studies. Pain Pract 2012;12(6):449-56. [link]
453 - Napp Laboratories (2000)
Napp Laboratories. A comparative efficacy and tolerability study of palladone capsules and MST continus tablets in patients with cancer pain. Data on file 2000.
454 - Newell SA (2002)
Newell SA, Sanson-Fischer RW. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst 2002;Apr; 94: 558-84. [link]
455 - Nguyen T (1997)
Nguyen T, Theobald S, Rougier P. Simultaneous high dose external irradiation and daily cisplatin in unresectable nonmetastatic adenocarcinoma of the pancreas; a phase I-II study. Radiother Oncol 1997;45:129-32. [link]
456 - Nicholson AB (2004)
Nicholson AB. Methadone for cancer pain. [Review] [62 refs][Update of Cochrane Database Syst Rev. 2004;(2):CD003971. [link]
457 - Nijs EJM de (2006)
Nijs EJM de, Verhagen EH. Richtlijn Klachten van de mond. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red).Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006:485- 520/ [link]
458 - Nikles J (2016)
Nikles J, Mitchell GK, Hardy J, et al. Single-patient multiple crossover studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: A pilot study. Palliat Med 2016; 30:800-802. [link]
459 - Nilsson S (2005)
Nilsson S, Strang P, Ginman C, et al. Palliation of bone pain in prostate cancer using chemotherapy and strontium-89. A randomized phase II study. J Pain Symptom Manage 2005;29:352-7. [link]
460 - Nishihara M (2013)
Nishihara M, Arai YC, Yamamoto Y, et al. Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Phys 2013;16(5):E547-E552. [link]
461 - Novotna S (2014)
Novotna S, Valentova K, Fricova J, et al. A randomized, placebo-controlled study of a new sublingual formulation of a fentanyl citrate (fentanyl etypharm) for breakthrough pain in opioid-treated patients with cancer. Clin Ther 2014;36:357-367. [link]
462 - Nunes BC (2014)
Nunes BC, dos Santos Garcia JB, Sakata RK. Morphine as first medication for treatment of cancer pain. Rev Bras Anesthesiol 2014;Jul-Aug; 64: 236-240. [link]
463 - Nunez-Olarte JM (2011)
Nunez-Olarte JM, Alvarez-Jimenez P. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain. J Pain Symptom Manage 2011;42:e6-8. [link]
464 - Oi-Ling K (2005)
Oi-Ling K, Man-Wah DTSE, Kam-hung DNG. Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life. Palliat Med 2005;19:228-33. [link]
465 - Okuyama M (2002)
Okuyama M, Shibata T, Morita T, et al. A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer. J Hepatobiliary Pancreat Surg 2002; 9: 372-5. [link]
466 - Oldenmenger WH (2013)
Oldenmenger WH, de Raaf PJ, de KC, et al. Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. [Review]. Journal of Pain & Symptom Management 2013;45(6):1083-93. [link]
467 - Oldenmenger WH (2011)
Oldenmenger WH, Sillevis Smitt PA, van Montfort CA, et al. A combined pain consultation and pain education program decreases average and current pain and decreases interference in daily life by pain in oncology outpatients: a randomized controlled trial. Pain (03043959) 2011;152(11):2632-9. [link]
468 - Oldenmenger WH (2006)
Oldenmenger WH, Stronks DL, Terwiel CTM, et al. Naar een landelijke, uniforme verpleegkundige Pijnanamnese. Psychometrische kwaliteiten. Nederlands Tijdschrift voor Pijnbestrijding 2006, nr 2: 2-6. [link]
469 - Oliver JW (2001)
Oliver JW, Kravitz RL, Kaplan SH, et al. Individualized patient education and coaching to improve pain control among cancer outpatients. Journal of Clinical Oncology 2001;19(8):2206-12. [link]
470 - Oliveira R de (2004)
Oliveira R de, Dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004; Jul; 110: 400-8. [link]
471 - Oliverio C (2012)
Oliverio C, Malone N, Rosielle DA. Opioid use in liver failure 260. J Palliat Med 2012;Dec; 15: 1389-1391. [link]
472 - Olmi P (1997)
Olmi P, Ausili Cefaro G, et al. Radiotherapy in the aged. Clin Geriatr Med 1997;13:143-68. [link]
473 - Oosten AW (2016)
Oosten AW, Abrantes JA, Jonsson J, et al. Treatment with subcutaneous and transdermal fentanyl: results from a population oharmacokinetic study in cancer patients. Br J Pharmacol 2016; 72: 459-467. [link]
474 - Oosterhof GO (2003)
Oosterhof GO, Roberts JT, de Reijke TM. Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group. Eur Urol 2003;44:519-26. [link]
475 - Oscarde Leon-Casasola MD (2005)
Oscar de Leon-Casasola REMaML. Neurolytic Visceral Sympathetic Blocks: Celiac Plexus Block, Superior Hypogastric Block, Ganglion Impar Block. In: SPEC - Essentials of Pain Medicine and Regional Anesthesia (Reprint)Dec 1 2005 Elsevier Inc, pp. 542-549. [link]
476 - Osoba D (1999)
Osoba D, Tannock IF, Ernst DS, et al. Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. J Clin Oncol 1999;17:1654-63. [link]
477 - Oztürk T (2008)
Oztürk T, Karadibak K, Catal D, et al. Comparison of TD-fentanyl with sustained-release morphine in the pain treatment. of patients with lung cancer. Agri 2008;20(3):20–5. [link]
478 - Pace MC (2007)
Pace MC, Passavanti MB, Grella E, et al. Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci 2007;12:1291-1299. [link]
479 - Panutti F (1999)
Panutti F, Della Cuna GR, Ventafridda V, et al. A double-blind evaluation of the analgesic efficacy and toxicity or oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study Group. Tumori 1999 Mar-Apr; 85: 96-100. [link]
480 - Passik SD (2011)
Passik SD, Messina J, Golsorkhi A, et al. Aberrant drug-related behavior observed during clinical studies involving taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage. 2011 Jan;41(1):116-25. [link]
481 - Patchell R (2005)
Patchell R, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-8. [link]
482 - Patel P (2004)
Patel P, Henry LL, Ganti AK, et al. Clinical course of lung cancer in patients with chronic kidney disease. Lung Cancer 2004;43:297-300. [link]
483 - Patt DB (1994)
Patt DB, Proper G, Reddy S. The neuroleptics as adjuvant analgetics. J Pain Symptom Manage 1994; 9: 446-453. [link]
484 - Paulsen O (2013)
Paulsen O, Aass N, Kaasa S, et al. Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. [Review]. Journal of Pain & Symptom Management 2013;46(1):96-105. [link]
485 - Paulsen O (2013)
Paulsen O, Kaasa S, Aass N, et al. Do methylprednisolone 32 mg provide pain relief, improve fatigue and appetite in cancer patients using opioids? A randomized, controlled trial. Eur J Cancer 2013;49:S270.
486 - Pautex S (2003)
Pautex S, Berger A, Chatelain C, et al. Symptom assessment in elderly cancer patients receiving palliative care. Crit Rev Oncol Hematol 2003;47:281-6. [link]
487 - Pavlakis N (2005)
Pavlakis N, Schmidt RL, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. [link]
488 - Payne R (2001)
Payne R, Coluzzi P, Hart L, et al. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. Journal of Pain & Symptom Management 2001;22(1):575-83. [link]
489 - Payne R (1998)
Payne R, Mathias SD, Pasta DJ, et al. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol 1998;16:1588-93. [link]
490 - Pellegrini A (1983)
Pellegrini A, Massidda B, Pellegrini B, et al. Effect of i.v. indoprofen on cancer pain and serum prolactin and growth hormone levels – a controlled pharmacological study vs i.m. morphine and placebo. Int J Clin Pharmacol Ther Toxicol 1983;Sep;21:483-6.
491 - Pergolizzi J (2008)
Pergolizzi J. Opioïds and the management of chronic severe pain in the elderly: consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioïds (Buprenorfine, Fentanyl,Hydromorphone, Methadone, Morphine, Oxycodone). Pain Pract 2008;Jul-Aug; 8: 287-313. [link]
492 - Piffanelli A (2001)
Piffanelli A, Dafermou A, et al. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group. Q J Nucl Med 2001;45:100-7. [link]
493 - Pigni A (2010)
Pigni A, Caraceni AT, Brunelli C. Systematic review on the role of hydromorphone for moderate to severe cancer pain: An EPCRC opioid guidelines project. Palliative Med 2010;24(4):S118.
494 - Plancarte R (1990)
Plancarte R, Amescua C, Patt RB, et al. Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990;Aug; 73: 236-9. [link]
495 - Plancarte R (1997)
Plancarte R, Leon Casasola OA de, El Helaly M, et al. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth 1997;Nov-Dec; 22: 562-8. [link]
496 - Polati E (1998)
Polati E, Finco G, Gottin L, et al. Prospective randomized double-blind trial of neurolytic coeliac plexus block in patients with pancreatic cancer. Br J Surg 1998;Feb; 85: 199-201. [link]
497 - Portenoy RK (2014)
Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014;Jun; 32: 1662-1670. [link]
498 - Portenoy RK (2010)
Portenoy RK, Burton AW, Gabrail N, et al. A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain. Pain 2010;151(3):617-24. [link]
499 - Portenoy RK (2010)
Portenoy RK, Raffaeli W, Torres LM, et al. Long-term safety, tolerability, and consistency of effect of fentanyl pectin nasal spray for breakthrough cancer pain in opioid-tolerant patients. J Opioid Manage 2010;6(5):319-28. [link]
500 - Portenoy RK (2006)
Portenoy RK, Taylor D, Messina J, et al. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006;22(9):805-11. [link]
501 - Porter AT (1993)
Porter AT, McEwan AJ, Powe JE. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Rad Onc Biol Phys 1993;25:805-13. [link]
502 - Porter J (1980)
Porter J, Jick H. Addiction rare in patients treated with narcotics. New Engl J Med 1980;Jan; 302:123. [link]
503 - Post-White J (2003)
Post-White J, Kinney ME, Savik K, et al. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther 2003;Dec; 2: 332-44. [link]
504 - Povedano M (2007)
Povedano M, Gascon J, Galvez R, et al. Cognitive Function Impairment in Patients with Neuropathic Pain Under Standard Conditions of Care. J Pain Symptom Manage 2007;33(1):78-89. [link]
505 - Puglisi G (1989)
Puglisi G, Garaguiola U. Pirprofen and pentazocine in the treatment of cancer pain. A double-blind, placebocontrolled study. Curr Ther Res Clin Exp 1989;45:333-8.
506 - Puli SR (2009)
Puli SR, Reddy JB, Bechtold ML, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sciences. 2009;Nov; 54: 2330-7. [link]
507 - Quigley C (2005)
Quigley C. The role of opioids in cancer pain. BMJ 2005;Oct 8;331: 825-829. [link]
508 - Quilty PM (1994)
Quilty PM, Kirk D, Bolger JJ. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994;31:33-40. [link]
509 - Radbruch R (2011)
Radbruch R, Trottenberg P, Elsner F, Kaasa S, Caraceni A. Systematic review on the role of alternative application routes for opioid treatment for moderate to severe cancer pain: An EAPC opioid guidelines project. Palliat Med 2011;Jul; 25: 578-596. [link]
510 - Rajasekaran M (2005)
Rajasekaran M, Edmonds PM, Higginson IL. Systematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients. Palliat Med 2005;19:418-26. [link]
511 - Rao AV (2004)
Rao AV, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain and depression. J Nat Cancer Institute Monogr 2004;32:150-7. [link]
512 - Rao RD (2008)
Rao RD, Flynn PJ, Sloan JA, et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 2008;112(12):2802-8. [link]
513 - Raptis E (2014)
Raptis E, Vadalouca A, Stavropoulou E, et al. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label Study. Pain Pract 2014;14(1):32-42. [link]
514 - Raslan AM (2011)
Raslan AM, Cetas JS, McCartney S, Burchiel KJ. Destructive procedures for control of cancer pain: the case for cordotomy. J Neurosurg. 2011; 114(1): 155-70. doi: 10.3171/2010.6.JNS10119. [link]
515 - Rauck R (2010)
Rauck R, North J, Gever LN, et al. Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study. Ann Oncol 2010;21(6):1308-14. [link]
516 - Rauck RL (2009)
Rauck RL, Tark M, Reyes E, et al. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Current Medical Research & Opinion 2009;25(12):2877-85. [link]
517 - Reddy S (1994)
Reddy S, Patt PB. The benzodiazepines as adjuvant analgetics. J Pain Symptom Manage 1994; 9: 510-514. [link]
518 - Reissig JE (2005)
Reissig JE, Rybarczyk AM. Pharmacological treatment of opioid-induced sedation in chronic pain. Ann Pharmacother 2005;39:727-31. [link]
519 - Remy C (2005)
Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomised controlled trials. Br J Anesthesia 2005;94:505-13. [link]
520 - Reni M (2005)
Reni M, Cordio S, Milandri C, et al. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. Lancet Oncol 2005;6:369-76. [link]
521 - Resche I (1997)
Resche I, Chatal J. A dose-controlled study of 153Sm-ethylenediaminetetramethyl- enephosphoante (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997;33:1583-91. [link]
522 - Rhee C (2007)
Rhee C, Broadbent AM. Palliation and liver failure: palliative medicine dosage guidelines. J Palliat Med 2007;Jun; 10: 677-685. [link]
523 - Rief H (2014)
Rief H, Welzel T, Omlor G, et al. Pain response of resistance training of the paravertebral musculature under radiotherapy in patiënts with spinal bone metastases--a randomized trial. BMC Cancer 2014;Jul; 14: 485. [link]
524 - Rizzo M (1990)
Rizzo M, Mazzei T, Mini E, et al. Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicenter trial. J Int Med Res 1990;18(Suppl 1):114-25. [link]
525 - Robb KA (2007)
Robb KA, Newham DJ, Williams JE. Transcutaneous electrical nerve stimulation vs. transcutaneous spinal electroanalgesia for chronic pain associated with breast cancer treatments. J Pain Symptom Manage 2007;Apr; 33(4): 410–9. [link]
526 - Robb KA (2006)
Robb KA, Williams JE, Duvivier V, et al. A pain management program for chronic cancer-treatment-related pain: a preliminary study. J pain 2006; 7: 82-90. [link]
527 - Roberto A (2016)
Roberto A, Deandrea S, Greco MT, et al. Prevalence of neuropathic pain in cancer patients: pooled estimates from a systematic review of published literature and results from a survey conducted in 50 Italian palliative care centers. J Pain Symptom Manage 2016;Jun; 51(6): 1091-1102. [link]
528 - Robinson R (1995)
Robinson R, Preston D. Strontium 89 therapy for the palliation of pain due to osseous metastases. JAMA 1995;274:420-4. [link]
529 - Rodriguez M (1994)
Rodriguez M, Barutell C, Rull M, et al. Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain. Eur J Cancer 1994;30A:584-7. [link]
530 - Rodriguez MJ (2003)
Rodriguez MJ, Contreras D, Galvez R, et al. Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain. Pain 2003;Jul;104:103-10. [link]
531 - Rodriguez-Bigas M (1991)
Rodriguez-Bigas M, Petrelli NJ, Herrera L, et al. Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. Surg Gynecol Obstet 1991;Jul; 173: 41-4. [link]
532 - Roos DE (2005)
Roos DE, Turner SL, O’Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005;75:54-63. [link]
533 - Roque M (2003)
Roque M, Martinez-Zapata M. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev. 2003;(4):CD003347. [link]
534 - Rosen J (2013)
Rosen J, Lawrence R, Bouchard M, et al. Massage for perioperative pain and anxiety in placement of vascular access devices. Adv Mind Body Med 2013; 27(1): 12–23. [link]
535 - Rosen LS (2004)
Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsch V, Krzakowski M, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung cancer and other solid tumors: a randomized, phase III, double-blind placebo-controlled trial. Cancer 2004;100:2613-2621. [link]
536 - Rosen LS (2003)
Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsch V, Krzakowski M, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, randomized trial – the zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol 2003;21:3150-3157. [link]
537 - Ross JR (2003)
Ross JR, Saunders Y, Edmonds PM, Patel S, Broadley K, Johnston SRD. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ 2003;327:469-472. [link]
538 - Ross JR (2004)
Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, Broadley K. A systematic review of the role of bisphosphonates in metastatic disease. Health Technol Assess 2004;8: 1-176. [link]
539 - Rustoen T (2014)
Rustoen T, Valeberg BT, Kolstad E, et al. A randomized clinical trial of the efficacy of a self-care intervention to improve cancer pain management. Cancer Nursing 2014;37(1):34-43. [link]
540 - Rustoen T (2012)
Rustoen T, Valeberg BT, Kolstad E, et al. The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management. J Pain Symptom Manage 2012;44(3):321-30. [link]
541 - Ruston T (2013)
Ruston T, Hunter K, Cummings G, Lazarescu L. Efficacy and side-effect profiles of lactulose, docusate sodium and sennosides compared to PEG in opioid-induced constipation: a systematic review. Can Oncol Nurs J. 2013; 23(4): 236-46. [link]
542 - Saad F (2002)
Saad F, Gleason DM, Murray R, Hussain A, Gittelman MC, Bilhartz DL, Wynne C, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate cancer. J Natl Cancer Inst 2002;94:1458-1468. [link]
543 - Saad F (2004)
Saad F, Gleason DM, Murray R, Hussain A, Gittelman MC, Bilhartz DL, Wynne C, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with hormone-refractory metastatic prostate cancer. J Natl Cancer Inst 2004;96:879-882. [link]
544 - Sacchetti G (1984)
Sacchetti G, Camera P, Rossi AP, et al. Injectable ketoprofen vs acetylsalicylic acid for the relief of severe cancer pain: a double-blind crossover trial. Drug Intell Clin Pharm 1984;May;18:403-6. [link]
545 - Salas S (2012)
Salas S, Frasca M, Planchet-Barraud B, et al. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. J Palliat Med 2012;15:287-293. [link]
546 - Salpeter RS (2013)
Salpeter RS, Buckley JS, Bruera E. The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Pall Med 2013;Jun;16(6):616-22. [link]
547 - Sande TA (2019)
Sande TA, Laird BJA, Fallon MT. The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med 2019; 22:90-97. [link]
548 - Sanders M (1995)
Sanders M, Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol 1995;Jun;13:1509-12. [link]
549 - Sartor O (2004)
Sartor O, Reid R. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology 2004;63:940-5. [link]
550 - Saunders C (1984)
Saunders C. The philosophy of terminal care. In: Sunders C (ed). The management of terminal malignant illness. Baltimore MD: Arnold Publishers, 1984, pp 232-241.
551 - Saxena A (1994)
Saxena A, Andley M, Gnanasekaran N. Comparison of piroxicam and acetylsalicylic acid for pain in head and neck cancers: a double-blind study. Palliat Med 1994; 8: 223-9. [link]
552 - Scherder EJA (2005)
Scherder EJA, Oosterman JM, Ooms ME, et al. Chronische pijn bij dementie en bij aandoeningen met een verhoogd risico op cognitieve achteruitgang. Tijdschr Gerontol Geriatr 2005;36:116-21.
553 - Schoeggl A (2002)
Schoeggl A, Reddy M. Neurological outcome following laminectomy in spinal metastases. Spinal Cord 2002;40:363-6. [link]
554 - Schug SA (1992)
Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Stmptom Manage 1992;Jul; 7:259-266. [link]
555 - Schumacher KL (2002)
Schumacher KL, Koresawa S. The usefulness of a daily pain management diary for outpatients with cancer-related pain. Oncol Nurs Forum 2002;29:1304-13. [link]
556 - Sciuto R (2002)
Sciuto R, Festa A. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med 2002;43:79-86. [link]
557 - Sciuto R (2001)
Sciuto R, Festa A. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast Cancer Res Treat 2001;66:101-9. [link]
558 - Sciuto R (1996)
Sciuto R, Maini C. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89. Nucl Med Commun 1996;17:799-804. [link]
559 - Serafini A (1998)
Serafini A, Houston S. Palliation of pain associated with metastatic bone cancer using Samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 1998;16:1574-81. [link]
560 - Serlin RC (1995)
Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate of severe? Grading pain severity by its interference with function. Pain 1995;61:277-284. [link]
561 - Sharma S (2009)
Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. Journal of Pain & Symptom Management 2009 Jan;37(1):85-93. [link]
562 - Shulman M (2000)
Shulman M, Harris JE, Lubenow TR, et al. Comparison of epidural butamben to celiac plexus neurolytic block for the treatment of the pain of pancreatic cancer. Clin J Pain 2000;Dec; 16: 304-9. [link]
563 - Silverman SM (2009)
Silverman SM. Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician 2009;May-Jun;12: 679-84. [link]
564 - Sivanesan E (2016)
Sivanesan E, Gitlin MC, Candiotti KA. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment. Anesthesia and analgesia. 2016;Oct;123(4):836-43. [link]
565 - Sjøgren P (1989)
Sjøgren P, Banning A. Pain, sedation and reaction tim during long-term treatment of cancer patients with oral and epidural opioids. Pain 1989;39:5-11. [link]
566 - Sjøgren P (1994)
Sjøgren P, Jensen NH, Jensen TS. Disappearance of morphine induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994;Nov; 59: 313-316. [link]
567 - Sjøgren P (1998)
Sjøgren P, Thunedborg LP, Christup L, et al. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term adminstration? Six case histories. Acta Anaesthesiol Scand 1998;Oct;42:1070-5. [link]
568 - Sjolund KF (2013)
Sjolund KF, Yang R, Lee KH, et al. Randomized atudy of pregabalin in patients with cancer-induced bone pain. Pain Ther 2013;2(1):37-48. [link]
569 - Slatkin NE (2003)
Slatkin NE, Rhiner M. Phenol saddle blocks for intractable pain at end of life: report of four cases and literature review. Am J Hosp Palliat Care 2003;Jan-Feb; 20: 62-6. [link]
570 - Slatkin NE (2007)
Slatkin NE, Xie F, Messina J, et al. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. The Journal of Supportive Oncology 2007;5(7):327-34. [link]
571 - Slavik E (2005)
Slavik E, Ivanovic S, Grujicic D, et al. Microsurgical spinothalamic chordotomy in the treatment of cancer pain. J BUON 2005;Apr-Jun; 10: 223-6. [link]
572 - Small EJ (2003)
Small EJ, Smith MR, Seaman JJ, Petrone Stephanie S, Kowalski MO. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer. J Clin Oncol 2003;21:4277-4284. [link]
573 - Smeland S (2003)
Smeland S, Erikstein B, Aas M. Role of strontium-89 as adjuvant to palliative external beam radiotherapy is ques- tionable: results of a double-blind randomized study. Int J Rad Onc Biol Phys 2003;56:1397-404. [link]
574 - Smith H (2012)
Smith H. A comprehensive review of rapid-onset opioids for breakthrough pain. [Review]. CNS Drugs 2012;26(6):509-35. [link]
575 - Smith EM (2013)
Smith EM, Pang H, Cirrincione C, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013;309(13):1359-67. [link]
576 - Smith HS (2013)
Smith HS. Considerations in selecting rapid-onset opioids for the management of breakthrough pain. J Pain Res 2013;6:189-200. [link]
577 - Smith MC (2002)
Smith MC, Kemp J, Hemphill L, et al. Outcomes of therapeutic massage for hospitalized cancer patiënts. J Nurs Scholarsh 2002; 34: 257-62. [link]
578 - Smith MY (2010)
Smith MY, DuHamel KN, Egert J, et al. Impact of a brief intervention on patient communication and barriers to pain management: results from a randomized controlled trial. Patient Education & Counseling 2010;81(1):79-86. [link]
579 - Smith TJ (2002)
Smith TJ, Peter SS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 2002;Oct; 20: 4040-9. [link]
580 - Soden K (2004)
Soden K, Vincent K, Craske S, et al. A randomized controlled trial of aromatherapy massage in a hospice setting. Palliat Med 2004;Mar; 18: 87-92.  [link]
581 - Soleimanpour H (2016)
Soleimanpour H, Safari S, Shahsavari Nia K, Sanaie S, Alavian SM. Opioid drugs in patients with liver disease: a systematic review. Hepat Mon 2016; 16(4): e32636. doi: 10.5812. [link]
582 - Soto E (2012)
Soto E, Stewart DR, Mannes AJ, et al. Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. [Review]. American Journal of Hospice & Palliative Medicine 2012;29(4):308-17. [link]
583 - Spiegel D (1997)
Spiegel D, Moore R. Imagery and hypnosis in the treatment of cancer patients. Oncology (Williston Park) 1997;11:1179. [link]
584 - Spiegel D (1994)
Spiegel D, Sands, Koopman C. Pain and depression in patients with cancer. Cancer 1994; 74: 2570-2578. [link]
585 - Spreeuwenberg C (2002)
Spreeuwenberg C, Bakker DJ, Dillmann RJM. Handboek palliatieve zorg. Maarssen: Elsevier Gezondheidszorg, 2002.
586 - Stambaugh J (1988)
Stambaugh J, Drew J. A double-blind parallel evaluation of the efficacy and safety of a single dose of ketoprofen in cancer pain. J Clin Pharmacol 1988; 28(Suppl 12): S34-9. [link]
587 - Stambaugh JE (1988)
Stambaugh JE, Drew J. The combination of ibuprofen and oxycodone/acetaminophen in the management of chronic cancer pain. Clin Pharmacol Ther 1988;Dec; 44: 665-9. [link]
588 - Stambaugh JE (1981)
Stambaugh JE, Sarajian C. Analgesic effect of zomepirac sodium in patients with pain due to cancer. J Clin Pharmacol 1981;Nov-Dec; 21: 501-7. [link]
589 - Stambaugh JE (1982)
Stambaugh JE. Additive analgesia of oral butorfanol/acetaminophen in patients with pain due to metastatic carcinoma. Curr Ther Res Clin Exp 1982;31:386-92.
590 - Staquet MJ (1993)
Staquet MJ, Renaud A. Double-blind, randomized trial of piroxicam and codeine in cancer pain. Curr Ther Res 1993;53:435-40.
591 - Staquet MJ (1989)
Staquet MJ. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain. J Clin Pharmacol 1989;29:1031-6. [link]
592 - Stefaniak T (2005)
Stefaniak T, Basinski A, Vingerhoets A, et al. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 2005;Sep; 31: 768-73. [link]
593 - Stockler MR (1998)
Stockler MR, Osoba D, Goodwin P, et al. Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the prostate cancer specific quality of life instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module.J Clin Epidem 1998;51:137-45. [link]
594 - Stockler M (2004)
Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomised, double-blind, placebo-controlled cross-over trial. J Clin Oncol 2004;Aug; 16: 3389-3394. [link]
595 - Stone P (2011)
Stone P. Minton O. European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? Palliat Med 2011; 25: 431-441. [link]
596 - Stoutz ND de (1995)
Stoutz ND de, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;Jul;10:378-84. [link]
597 - Stoutz ND de (1995)
Stoutz ND de, Tapper M, Fainsinger RL. Reversibel delirium in terminally ill patients. J Pain Symptom Manage 1995;10:249-53. [link]
598 - Straube C (2014)
Straube C, Derry D, Jackson, et al. Codeine, alone and with paracetamol (acetaminophen), for cancer pain. Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006601. [link]
599 - Strobel E (1992)
Strobel E. Drug therapy in severe tumor pain. Comparative study of a new combination preparation versus diclofenac- Na. Fortschr Med 1992;Aug; 110: 411-4. [link]
600 - Stuart G (1993)
Stuart G, Cramond T. Role of percutaneous cervical cordotomy for pain of malignant origin. Med J Aust 1993;May;158: 667-70. [link]
601 - Süleyman Ozyalçin N (2004)
Süleyman Ozyalçin N, Talu GK, Camlica H, et al. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Eur J Pain 2004;8:539-45. [link]
602 - Sullivan BA (1995)
Sullivan BA, McKinnis R, Laufman LR. Quality of life in patients with metastatic colorectal cancer receiving chemotherapy: a randomized, double-blind trial comparing 5-FU versus 5-FU with leucovorin. Pharmacother 1995;15:600-7. [link]
603 - Suno M (2015)
Suno M, Endo Y, Nishie H, Kajizono M, Sendo T, Matsuoka J. Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients.Ther Clin Risk Manag 2015;11:751-7. [link]
604 - Sunshine A (1988)
Sunshine A, Olson NZ. Analgesic efficacy of ketoprofen in postpartum, general surgery, and chronic cancer pain. J Clin Pharmacol 1988;28(Suppl 12):S47-50. [link]
605 - Sussman G (1999)
Sussman G, Shurman J, Creed MR, et al. Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group. Clin Ther 1999;21:1216-27. [link]
606 - Sutton LM (2003)
Sutton LM, Denmark-Wahnefried W, Clipp EC. Management of terminal cancer in elderly patients. Lancet Oncol 2003;Mar; 4: 149-57. [link]
607 - Swartjes M (2013)
Swartjes M, Niesters M, Heij L, et al. Ketamine does not produce relief of neuropathic pain in mice lacking the ?- common receptor (CD131). PLoS one 2013;8(8):e71326. [link]
608 - Syrjala KL (2008)
Syrjala KL, Abrams JR, Polissar NL, et al. Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain. 2008 Mar;135(1-2):175-86. [link]
609 - Sze WM (2004)
Sze WM, Mike S, Ines H, et al. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev 2004;CD004721. [link]
610 - Sze WM (2003)
Sze WM, Shelley MD, Held I, et al. Palliation of metastatic bone pain: single fraction versus mulifraction radiotherapy. A systematic review of randomised trials. Clin Oncol (R Coll Radiol ) 2003;15:345-52. [link]
611 - Takamura Y (2005)
Takamura Y, Miyauchi A, Tomoda C, Uruno T, Ito Y, Miya A, et al. Stretching exercises to reduce symptoms of postoperative neck discomfort after thyroid surgery: prospective randomized study. World J Surg 2005;29:775-9. [link]
612 - Talbot M (2005)
Talbot M, Turcotte R. Function and health status in surgically treated bone metastases. Clin Orthop Relat Res 2005;438:215-20. [link]
613 - Tannock IK (2004)
Tannock IK, Wit R de, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. New Engl J Med 2004;351:1502-12. [link]
614 - Tasmacioglu T (2009)
Tasmacioglu T, Aydinli I, Keskinbora K, Pekel AF, Salihoglu T, Sonsuz A. Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support Care Cancer 2009;Dec; 17:1 475-1481. [link]
615 - Tassinari D (2011)
Tassinari D, Drudi F, Rosati M, et al. The second step of the analgesic ladder and oral tramadol in de treatment of mild to moderate cancer pain: a systematic review. Palliat Med 2011;Jul; 25: 410-423. [link]
616 - Tassinari D (2011)
Tassinari D, Drudi F, Rosati M, et al. Transdermal opioids as front line treatment of moderate to severe cancer pain: a systemic review. [Review]. Palliative Med 2011;25(5):478-87. [link]
617 - Tassinari D (2008)
Tassinari D, Sartori S, Tamburini E, et al. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. [Review] [34 refs]. J Palliative Med 2008;11(3):492-501. [link]
618 - Tatrow K (2006)
Tatrow K, Montgomery GH. Cognitive behavioral therapy techniques for distress and pain in breast cancer patients: a meta-analysis. J Behav Med 2006;29(1):17. [link]
619 - Taylor AG (2003)
Taylor AG, Galper DI, Taylor P, et al. Effects of adjunctive Swedish massage and vibration therapy on short-term postoperative outcomes: a randomized, controlled trial. J Altern Complement Med 2003;Feb; 9: 77-89. [link]
620 - Taylor D (2014)
Taylor D, Radbruch L, Revnic J, et al. A Report on the Long-term Use of Fentanyl Pectin Nasal Spray in Patients With Recurrent Breakthrough Pain. J Pain Symptom Manage. 2014 Jun;47(6):1001-7. [link]
621 - Taylor RS (2006)
Taylor RS, Taylor RJ. Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine 2006;31:2747-55. [link]
622 - Teunissen S (2002)
Teunissen S, Witteveen E. Organisatie van palliatieve zorg. In: Spreeuwenberg C, (red) et al. Handboek palliatieve zorg. Maarssen: Elsevier Gezondheidszorg, 2002.
623 - Teunissen SCCM (2007)
Teunissen SCCM, Wesker W, Kruitwagen C, et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007 Jul;34(1):94-104. [link]
624 - Thomas ML (2012)
Thomas ML, Elliott JE, Rao SM, et al. A randomized, clinical trial of education or motivational-interviewing-based coaching compared to usual care to improve cancer pain management. Oncol Nursing Forum 2012;39(1):39-49. [link]
625 - Tian J (1999)
Tian J, Zhang J. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylenediaminete-tramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Eur J Nucl Med 1999;26:2-7. [link]
626 - Timmerman H (2013)
Timmerman H, Wolff AP, Schreyer T, et al. Cross-cultural adaptation to the Dutch language of the PainDETECT- Questionnaire. Pain Pract 2013;13(3):206-14. [link]
627 - Tonachella R (1985)
Tonachella R, Curcio CG, Grossi E. Diclofenac sodium in cancer pain: a double-blind within-patients comparison with pentazocine. Curr Ther Res Clin Exp 1985;37:1130-3.
628 - Toscani F (1993)
Toscani F, Galucci M, Scaricabarozzi I. Nimesulide in the treatment of advanced cancer pain. Double-blind comparison with naproxen. Drugs 1993; 46(Suppl 1):1 56-8. [link]
629 - Toscani F (1994)
Toscani F, Piva L, Galluci M, et al. Ketorolac versus diclofenac sodium in cancer pain. Arzneimittelforschung 1994;Apr; 44: 550-4. [link]
630 - Toth M (2013)
Toth M, Marcantonio ER, Davis RB, et al. Massage therapy for patiënts with metastatic cancer: a pilot randomized controlled trial. J Altern Complement Med 2013;Jul; 19: 650-656. [link]
631 - Toy E (2003)
Toy E, Macbeth F, Coles B. Palliative thoracic radiotherapy for non-small cell lung cancer: a systematic review. Am J Clin Oncol 2003;26:112-20. [link]
632 - Tse MM (2012)
Tse MM, Wong AC, Ng HN, et al. The effect of a pain management program on patients with cancer pain. Cancer Nursing 2012;35(6):438-46. [link]
633 - Tu S (2001)
Tu S, Millikan R. Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomized phase II trial. Lancet 2001;357:336-41. [link]
634 - Tuncer S (2003)
Tuncer S, Pirbudak L, Balat O, et al. Adding ketoprofen to intravenous patient-controlled analgesia with tramadol after major gynaecological cancer surgery: a double-blinded, randomised, placebo-controlled clinical trial. Eur J Gynaecol Oncol 2003; 24: 181-4. [link]
635 - Turnbull R (1986)
Turnbull R, Hills LJ. Naproxen versus aspirin as analgesics in advanced malignant disease. J Palliat Care 1986;Apr; 1: 25-8. [link]
636 - Twycross R (1976)
Twycross R. The measurement of pain in terminal carcinoma. Journal of International Medical Research 1976;4(Suppl 2):58–67. [link]
637 - Twycross RG (1977)
Twycross RG. Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 1977;3:93–104. [link]
638 - Uhle EI (2000)
Uhle EI, Becker R, Gatscher S, et al. Continuous intrathecal clonidine administration for the treatment of neuropathic pain. Stereotact Funct Neurosurg 2000;75:167-75. [link]
639 - Vallieres I (2006)
Vallieres I, Aubin M, Blondeau L, et al. Effectiveness of a clinical intervention in improving pain control in outpatients with cancer treated by radiation therapy. International Journal of Radiation Oncology, Biology, Physics 2006;66(1):234-7. [link]
640 - Vamvakas S (1998)
Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved. Am J Nephrol 1998;18:89-95. [link]
641 - Van den Beuken-van Everdingen MH (2016)
Van den Beuken-van Everdingen MH, Hochstenbach LM, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016;Jun; 51: 1070-1090. [link]
642 - Van der Linden YM (2005)
Van der Linden YM, Dijkstra SP. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103:320-8. [link]
643 - Van der Linden YM (2004)
Van der Linden YM, Lok JJ, Steenland E. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys 2004;59:528-37. [link]
644 - Van der Peet EH (2009)
Van der Peet EH, van den Beuken-van Everdingen MH, Patijn J, et al. Randomized clinical trial of an intensive nursing-based pain education program for cancer outpatients suffering from pain. SUPPORT CARE CANCER 2009;17(8):1089-99. [link]
645 - Van der Peet EH (2004)

Van der Peet EH. Effectevaluatie Herstel en Balans 1997-2002. [Eindexamen Gezondheidswetenschappen.] Maastricht: Universiteit Maastricht, 2004.

646 - Van Ojik AL (2012)
Van Ojik AL, Jansen PA, Brouwers JR, et al. Treatment of chronic pain in older people. Drugs Aging. 2012 Aug 1;29(8):615-25. [link]
647 - Van Seventer R (2003)
Van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Current Medical Research and Opinion 2003;19(6):457-69. [link]
648 - Van Seventer R (2013)
Van Seventer R, Vos C, Giezeman M, et al. Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract 2013;13(5):390-8. [link]
649 - Van Zuylen (2010)
Van Zuylen, van Veluw H, van Es J. Richtlijn Zorg in de stervensfase, 2010. [link]
650 - Vansteenkiste J (2003)
Vansteenkiste J, Vandebroek J, Nackaerts K, et al. Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. Lung Cancer 2003;40:191-9. [link]
651 - Vecht CJ (1989)
Vecht CJ, Haaxma-Reice H, Putten WL van, et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-7. [link]
652 - Velasquez Rivera I (2014)
Velasquez Rivera I, Munos Garrido J, Garcia Velasco P, et al. Efficazcy of sublingul fentanyl vs. oral morphine for cancer-related breakthrough pain. Adv Ther 2014;31:107-117. [link]
653 - Vella-Brincat V (2004)
Vella-Brincat V, MacLeod AD. Haloperidol in palliative care. Palliative Med 2004;18:195-201. [link]
654 - Ventafridda V (1990)
Ventafridda V, Conno F de, Panerai AE, et al. Non-steroidal anti-inflammatory drugs as the first step in cancer pain therapy: double-blind within-patient study comparing nine drugs. J Int Med Res 1990;Jan-Feb; 18: 21-9. [link]
655 - Ventafridda V (1975)
Ventafridda V, Martino G, Mandeli V, et al. Indoprofen, a new analgesic and anti-inflammatory drug in cancer pain. Clin Pharmacol Ther 1975;17:284-9. [link]
656 - Ventafridda V (1990)
Ventafridda V, Toscani F, Tamburini M, et al. Sodium naproxen versus sodium diclofenac in cancer pain control. Arzneimittelforschung 1990;Oct; 40: 1132-4. [link]
657 - Verberkt CA (2017)
Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Respir J 2017;Nov 22;50(5). pii: 1701153.doi: 10.1183/13993003.01153-2017. [link]
658 - Verenso (2011)
Verenso. Multidisciplinaire Richtlijn Pijn. 2011. [link]
659 - Verhagen EH (2006)
Verhagen EH, Bannink M, Krol RJA. Richtlijn delier. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006:167-94. [link]
660 - Verhagen EH (2006)
Verhagen EH, Taphoorn MJB, Krol RJA. Richtlijn hersenmetastasen. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006:343-59. [link]
661 - Vernassiere C (2005)
Vernassiere C, Cornet C, Trechot P, et al. Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care 2005;Jun; 14: 289-93. [link]
662 - Verrees J (1996)
Verrees J, Fernandez-Trigo V. Rectal cancer recurrence after prior resection and radiotherapy: palliation following additional surgery. Int J Colorectal Dis 1996;11:211-6. [link]
663 - Vilholm OJ (2008)
Vilholm OJ, Cold S, Rasmussen L, et al. Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol 2008;15(8):851-7. [link]
664 - Vissers DC (2011)
Vissers DC, Lenre M, Tolley K, et al. An economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancer. Value Health 2011;14:274-281. [link]
665 - Volkow ND (2016)
Volkow ND, Mclellan AT. Opioid abuse in chronic pain - misconceptions and mitigation. N Engl J Med 2016;Mar 31;374:1253-1263. [link]
666 - Vorobeychik Y (2008)
Vorobeychik Y, Chen L, Bush MC, et al. Improved opioid anagesic effect following opioid dose reduction. Pain Medicine 2008;Sep; 9: 724-7. [link]
667 - Vranken JH (2002)
Vranken JH, Vegt MH van der, Ubags LH, et al. Continuous sacral nerve root block in the management of neuropathic cancer pain. Anesth Analg 2002;95:1724-5. [link]
668 - Walker G (2003)
Walker G, Wilcock A, Manderson C, et al. The acceptability of different routes of administration of analgesia for breakthrough pain. Palliative Med 2003;17(2):219-21. [link]
669 - Wallace KG (1997)
Wallace KG. Analysis of recent literature concerning relaxation and imagery interventions for cancer pain. Cancer Nurs 1997;Apr; 20: 79-88. [link]
670 - Wallenstein SL (1980)
Wallenstein SL, Rogers A, Kaiko RF, et al. Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain. J Clin Pharmacol 1980;20:250-8. [link]
671 - Wang J (2004)
Wang J, Boland P. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. J Neurosurg Spine 2004;1:287-98. [link]
672 - Wang YM (2012)
Wang YM, Liu ZW, Liu JL, et al. Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials. Exp Ther Med 2012;4(2):249-54. [link]
673 - Ward S (2008)
Ward S, Donovan H, Gunnarsdottir S, et al. A randomized trial of a representational intervention to decrease cancer pain (RIDcancerPain). Health Psychology 2008;27(1):59-67. [link]
674 - Ward SE (2009)
Ward SE, Serlin RC, Donovan HS, et al. A randomized trial of a representational intervention for cancer pain: does targeting the dyad make a difference? Health Psychology 2009;28(5):588-97. [link]
675 - Ward SE (2009)
Ward SE, Wang KK, Serlin RC, et al. A randomized trial of a tailored barriers intervention for Cancer Information Service (CIS) callers in pain. Pain. 2009 Jul;144(1-2):49-56. [link]
676 - Ward W (2003)
Ward W, Holsenbeck S. Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res 2003; 415(Suppl):S230-44. [link]
677 - Warner MA (1991)
Warner MA, Hosking MP, Gray JR, et al. Narcotic-induced histamine release: A comparison of morphine, oxymorphone, and fentanyl infusions. J Cardiothorac Vasc Anesth 1991;5:481-4. [link]
678 - Wasil T (2000)
Wasil T, Lichtman SM, Gupta V, et al. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000;23:526-30. [link]
679 - Watanabe S (1994)
Watanabe S, Bruera E. Corticosteroids as adjuvant analgetics. J Pain Symptom Manage 1994;9:442-5. [link]
680 - Webster L (2003)
Webster L, Andrews M, Stoddard G. Modafinil treatment of opioid-induced sedation. Pain Med 2003;Jun;4:135-40. [link]
681 - Wedding U (2003)
Wedding U, Höffken K. Care of breast cancer in the elderly woman-what does comprehensive geriatric assessment (CGA) help? Support Care Cancer 2003;11:769-74. [link]
682 - Weersink RA (2018)
Weersink RA, Bouma M, Burger DM, et al. Evidence-based recommendationsto improve the safe use of drugs in patients with liver cirrhosis. Drug Saf 2018;Jun;41(6):603-613. doi: 10.1007/s40264-017-0635-x. [link]
683 - Weert E van (2005)
Weert E van, Hoekstra-Weebers J, Grol B, et al. A multidimensional cancder-rehabilitation program for cancer survivors: effectiveness on health-related quality of life. J Psychosom Res 2005; 58: 485-496. [link]
684 - Weide van der M (2003)
Weide van der M, Vielvoye-Kerkmeer, Verkerk N. Mastectomie Pijn Syndroom (PMPS), een vroege behandeling voor een betere kwaliteit van leven. NTPP 2003;22(14):20-23.
685 - Weill A (1996)
Weill A, Chiras J, Simon JM, et al. Spinal metastases: indications for and results of percutaneous injection of acrylic surgical cement. Radiology 1996;199:241-7. [link]
686 - Weingart WA (1985)
Weingart WA, Sorkness CA, Earhart RH. Analgesia with oral narcotics and added ibuprofen in cancer patients. Clin Pharm 1985;Jan-Feb; 4: 53-8. [link]
687 - Weinrich SP (1990)
Weinrich SP, Weinrich MC. The effect of massage on pain in cancer patiënts. Appl Nurs Res 1990;Nov; 3(4): 140–5. [link]
688 - Weinstein SM (2009)
Weinstein SM, Messina J, Xie F. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: A long-term, open-label safety study. Cancer 2009;115(11):2571-9. [link]
689 - Wells N (2003)
Wells N, Hepworth JT, Murphy BA, et al. Improving cancer pain management through patient and family education. J Pain Symptom Manage 2003;25(4):344-56. [link]
690 - Wells N (2004)
Wells N, Murphy B, Douglas S, et al. Establishing the safety and efficacy of an opioid titration protocol. Am J Hosp Palliat Care 2004;21:373-80. [link]
691 - Weschules DJ (2008)
Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Medicine 2008;9(3):315-44. [link]
692 - Wiffen PJ (2014)
Wiffen PJ, Derry S, Moore RA. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain. Cochrane Database Syst Rev 2014;5:CD011056. [link]
693 - Wiffen PJ (2017)
Wiffen PJ, Derry S, Moore RA. Tramadol with or without paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev 2017; 5: CD012508. [link]
694 - Wiffen PJ (2017)
Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;Jul 6;7:CD012592. [link]
695 - Wiffen PJ (2013)
Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2013 Jul 22;(7):CD003868. [link]
696 - Wiffen PJS (2017)
Wiffen PJS, Derry Moore RA, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev 2017;Jul 12;7:CD012637. [link]
697 - Wilkie DJ (2000)
Wilkie DJ, Kampbell J, Cutshall S, et al. Effects of massage on pain intensity, analgesics and quality of life in patiënts with cancer pain: A pilot study of a randomized clinical trial conducted within hospice care delivery. Hosp J 2000; 15(3):31–53. [link]
698 - Wilkinson TJ (1992)
Wilkinson TJ, Robinson BA, Begg EJ, Duffull SB, Ravenscroft PJ, Schneider JJ. Pharmocokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients. Cancer Chemother Pharmacol 1992; 31: 251-254. [link]
699 - Williams AF (2002)
Williams AF, Vadgama A, Franks PJ, et al. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl) 2002;11:254-61. [link]
700 - Wilson GR (2003)
Wilson GR, Reisfield GM. Morphine hyperalgesia: a case report. Am J Hosp Palliat Care 2003;Nov-Dec; 20: 459e461. [link]
701 - Wilwerding MB (1995)
Wilwerding MB, Loprinzi CL, Mailliard JA, et al. A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer 1995;Mar;3:135-8. [link]
702 - Winell J (2005)
Winell J, Roth AJ. Psychiatric assessment and symptom management in elderly cancer patients. Oncology (Williston Park). 2005 Oct;19(11):1479-9. [link]
703 - Wirz S (2005)
Wirz S, Klaschik E. Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? Am J Hosp Palliat Care 2005;Sep-Oct;22:375-81. [link]
704 - Wirz S (2008)
Wirz S, Wartenberg HC, Nadstawek J. Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain. Support Care Cancer. 2008 Sep;16(9):999-1009. [link]
705 - Wirz S (2009)
Wirz S, Wittmann M, Schenk M, et al. Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. Eur J Pain 2009;13:737–743. [link]
706 - Wong GY (2004)
Wong GY, Schroeder DR, Carns PE, et al. Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 2004;Mar 3;291:1092-9. [link]
707 - Wong JO (1997)
Wong JO, Chiu GL, Tsao CJ, et al. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiologica Sinica 1997;35(3):25–32. [link]
708 - Wong R (2000)
Wong R, Malthaner R. Esophageal cancer: a systematic review. Curr Probl Cancer 2000;24:297-373. [link]
709 - Wong R (1996)
Wong R, Thomas G, Cummings B. The role of radiotherapy in the management of pelvic recurrence of rectal cancer. Can J Oncol 1996;6(Suppl 1):39-47. [link]
710 - Wong R (2002)
Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002, CD002068. [link]
711 - Wool C (1991)
Wool C, Prandoni P, Polistena P, et al. Ketorolac suppositories in the treatment of neoplastic pain: a randomized clinical trial versus diclofenac. Curr Ther Res Clin Exp 1991;49: 854-61.
712 - Wu JS (2003)
Wu JS, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605. [link]
713 - Wunder J (2003)
Wunder J, Ferguson P. Acetabular metastases: planning for reconstruction and review of results. Clin Orthop Relat Res 2003;415(Suppl):S187-97. [link]
714 - Wyse JM (2011)
Wyse JM, Carone M, Paquin SC, et al. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;Sep 10;29(26):3541-6. [link]
715 - Yaksh TL (2003)
Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003; 99: 174-87. [link]
716 - Yalçn S (1998)
Yalçn S, Güllü IH, Tekuzman G, et al. A comparison of two nonsteroidal antiinflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain: a randomized crossover study. Am J Clin Oncol 1998;Apr; 21:185-8. [link]
717 - Yalçn S (1997)
Yalçn S, Güllü IH, Tekuzman G, et al. Ketorolac tromethamine in cancer pain. Acta Oncol 1997; 36: 232. [link]
718 - Yan BM (2007)
Yan BM, Myers RP. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. The American journal of gastroenterology. 2007;Feb;102:430-8. [link]
719 - Yan PZ (2014)
Yan PZ, Butler PM, Kurowski D, et al. Beyond neuropathic pain: Gabapentin use in cancer pain and perioperative pain. Clin J Pain. 2014 Jul;30(7):613-29. [link]
720 - Yang Q (2010)
Yang Q, Xie DR, Jiang ZM, et al. Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysis. Journal of Experimental & Clinical Cancer Research 2010;29:67. [link]
721 - Yates P (2004)
Yates P, Aranda S, Edwards H, et al. Family caregivers’ experiences and involvement with cancer pain management. J Palliat Care 2004;20:287-96. [link]
722 - Yates P (2004)
Yates P, Edwards H, Nash R, et al. A randomized controlled trial of a nurse-administered educational intervention for improving cancer pain management in ambulatory settings. Patient Education & Counseling 2004;53(2):227-37. [link]
723 - Yates PM (2002)
Yates PM, Edwards HE, Nash RE, et al. Barriers to effective cancer pain management: a survey of hospitalized cancer patients in Australia. J Pain Symptom Manage 2002;May;23:393-405. [link]
724 - Yuen KK (2006)

Yuen KK, Shelley M, Sze WM, Mason MD. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev 2006, CD006250. [link]

725 - Yennurajalingam S (2005)
Yennurajalingam S, Braiteh F, Bruera E. Pain and terminal delirium research in the elderly. Clin Geriatr Med 2005;21:93-119. [link]
726 - Yeung R (1993)
Yeung R, Moffat F. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 1993;15:1853-8. [link]
727 - Yildirim YK (2009)
Yildirim YK, Cicek F, Uyar M. Effects of pain education program on pain intensity, pain treatment satisfaction, and barriers in Turkish cancer patients. Pain Management Nursing 2009;10(4):220-8. [link]
728 - Yousef AAA (2014)
Yousef AAA, El-mashad NM. Pre-emptive Value of Methylprednisolone Intravenous Infusion in Patients With Vertebral Metastasis. A Double-Blind Randomized Study. J Pain Symptom Manage. 2014 Nov;48(5):762-9. [link]
729 - Yuan CS (1999)
Yuan CS, Foss JF, O’Connor M, et al. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain 1999;83:631-5. [link]
730 - Yuan CS (2000)
Yuan CS, Foss JF, O’Connor M, et al. Methylnaltexone for reversal of constipation due to chronic methadone use:A randomized controlled trial. JAMA 2000;283:367-72. [link]
731 - Zaza C (2002)
Zaza C, Baine N. Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage 2002;24:526-542. [link]
732 - Zeppetella G (2014)
Zeppetella G, Davies A, Eijgelshoven I, et al. A network meta-analysis of the efficacy of opioid analgesics for the management of breakthrough cancer pain episodes. J Pain Symptom Manage 2014;47(4):772-85. [link]
733 - Zeppetella G (2013)
Zeppetella G, Davies AN. Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev 2013;10:CD004311. [link]
734 - Zeppetella G (2005)
Zeppetella G, Ribeiro MD. Morphine in intrasite gel applied topically to painful ulcers. J Pain Symptom Manage 2005;Feb; 29(2): 118-9. [link]
735 - Zhang CL (2008)
Zhang CL, Zhang TJ, Guo YN, et al. Effect of neurolytic celiac plexus block guided by computerized tomography on pancreatic cancer pain. Digestive diseases and sciences. 2008;Mar; 53: 856-60. [link]
736 - Zhong W (2014)
Zhong W, Yu Z, Zeng JX, et al. Celiac plexus block for treatment of pain associated with pancreatic cancer: a meta-analysis. Pain practice. 2014;Jun;14: 43-51. [link]
737 - Zundert J van (2009)
Zundert J van, Huygen F, Patijn J et al. Praktische richtlijnen anesthesiologische pijnbestrijding. Maastricht, 2009.
738 - Zwakhalen SM (2006)
Zwakhalen SM, Hamers JP, Berger MP. The psychometric quality and clinical usefulness of three pain assessment tools for elderly patients with dementia. Pain 2006;126:210-20. [link]
739 - Zylicz Z (2003)
Zylicz Z, Krajnik M, Sorge AA, et al. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 2003;26:1105-12. [link]
740 - Zylicz Z (1998)
Zylicz Z, Smits C, Krajnik M. Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 1998;16:121-4. [link]
741 - Zylicz Z (2006)
Zylicz Z, Teunissen SCCM, Graeff A de. Inleiding. In: Graeff A de, Hesselmann GM, Krol RJA, et al (red). Palliatieve zorg. Richtlijnen voor de praktijk. Utrecht: Vereniging van Integrale Kankercentra, 2006:13-32.
742 - Antila H (1998)
Antila H, Kirvela O. Neurolytic thoracic paravertebral block in cancer pain. A clinical report. Acta Anaesthesiol Scand 1998;42:581-5. [link]
743 - Bouhassira D (2005)
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114: 29-36. [link]
744 - Davies DD (1993)
Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med. 1993; 86: 264–266. [link]
745 - Durand JP (2012)
Durand JP, Deplanque G, Montheil V, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012;23(1):200-5. [link]
746 - Forrest WH Jr (1977)
Forrest WH Jr, Brown BW Jr, Brown CR, et al. Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med. 1977;296(13):712–715. [link]
747 - Fredheim OM (2008)
Fredheim OM, Moksnes K, Borchgrevink PC, Kaasa S, Dale O. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand. 2008; 52: 879–889. [link]
748 - Haase O (2005)
Haase O, Schwenk W, Hermann C, Müller JM. Guided imagery and relaxation in conventional colorectal resections: a randomized, controlled, partially blinded trial. Dis Colon Rectum. 2005;48(10):1955–1963. [link]
749 - Higginson I (1990)
Higginson I, Wade A, McCarthy M. Palliative care: views of patients and their families. BMJ 1990;301:277-81. [link]
750 - Ischia S (1992)
Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology. 1992;76(4):534–540. [link]
751 - Ji RR (2001)
Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol Dis. 2001; 8: 1-10. [link]
752 - Jimenez-Andrade JM (2010)
Jimenez-Andrade JM, Mantyh PW et al. Bone Cancer Pain. Ann N Y Acad Sci. 2010 Jun;1198:173-81. [link]
753 - Kalso E (1996)
Kalso E, Heiskanen T, Rantio M, Rosenberg PH, Vainio A. Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study. Pain. 1996;67(2-3):443–449. [link]
754 - Leppert W (2009)
Leppert W. The role of methadone in cancer pain treatment--a review. Int J Clin Pract. 2009;63(7):1095–1109. doi:10.1111/j.1742-1241.2008.01990.x [link]
755 - Mercadante 1999 (1999)
Mercadante 1999, Casuccio A, Agnello A, et al. Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms. J Pain Symptom Manage 1999; 17: 351-356. [link]
756 - Mercadante S (2002)
Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002 May-Jun;88(3):239-42. [link]
757 - Nabal M (2012)
Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012; 26: 305-12. [link]
758 - Niv D (1992)
Niv D, Chayen MS. Reduction of localized cancer pain by percutaneous dorsal root ganglia lesions. Pain Clinic 1992;5:229-34
759 - Olkkola KT (2009)
Olkkola KT, Hagelberg NM. Oxycodone: new 'old' drug. Curr Opin Anaesthesiol. 2009; 22: 459–462. [link]
760 - Reid CM (2006)
Reid CM, Martin RM, Sterne JAC, Davies AN and Hanks GW. Oxycodone for cancer-related pain: Meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 837–843. [link]
761 - Schrottner O (1991)
Schrottner O. Results of percutaneous cordotomy in lung and breast cancer. A comparative study with strong support for a multidimensional nature of pain. Pain Clinic 1991;4:217-22
762 - Stam J (2001)
Stam J, Veld K in ‘t. Het einde is in zicht. Over begeleiding naar het levenseinde. Cahiers over communicatie en attitude. Utrecht, BHG, 2001
763 - Takahashi H (2010)
Takahashi H, Shimoyama N. A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain. Int J Clin Oncol. 2010; 15:46–51. [link]
764 - Tsavaris N (2008)
Tsavaris N, Kopterides P, Kosmas C, et al. Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study. Pain Med. 2008; 9: 1209–1216. [link]
765 - Walsh TD (1986)
Walsh TD. Controlled study of imipramine and morphine in chronic pain due to advanced cancer (published abstract). Proceedings of ASCO 1986; 237
766 - Wilkinson SM (2007)
Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. J Clin Oncol. 2007; 25(5): 532-539 [link]
767 - Zeppetella G (2003)
Zeppetella G, Paul J, Ribeiro MD. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage. 2003; 25: 555-8. [link]